Systems and methods for delivering biomaterials - Patents.com
The delivery device addresses precision and safety issues in biomaterial delivery by controlling the simultaneous delivery of two components to form hydrogels within predetermined speed and force ranges, ensuring accurate and safe delivery to specific body lumens, and supporting multiple location delivery and priming fluid integration.
Patent Information
- Application Number
- JP2021523237
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-11-13
- Filing Date
- 2019-11-12
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2039-11-12
AI Technical Summary
Existing delivery systems for biomaterials, such as hydrogels, lack precision and control over volume, rate, and force, leading to inconsistent and potentially harmful delivery, especially for small volumes, and do not support simultaneous delivery to multiple locations or include priming fluids for target site preparation.
A delivery device with a shroud and drive assembly that controls the simultaneous delivery of two components from separate containers, using an electromechanical drive and electronic control system to maintain predetermined speed and force ranges, allowing for precise formation and delivery of hydrogels to specific body lumens, with optional priming fluid integration.
Ensures safe and accurate delivery of controlled microvolumes of hydrogels to target sites, minimizing tissue damage and ensuring complete formation within the delivery system, while allowing for simultaneous delivery to multiple locations and preparation of the target site.
Smart Images

Figure 0007582939000001 
Figure 0007582939000002 
Figure 0007582939000003
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority to U.S. Provisional Patent Application No. 62 / 760,650, entitled "Methods and Apparatus for Automated, Microvolume Delivery of Biomaterials," filed November 13, 2018, which is incorporated by reference in its entirety. [Background technology]
[0002] FIELD OF THE DISCLOSURE
[0002] Embodiments described herein relate generally to delivery devices and methods for delivering biomaterials, and more specifically, to controlling the formation and delivery of hydrogels into body lumens.
[0003] Biomaterials are natural or synthetic substances (such as polymers) suitable for introduction into living tissues as therapeutic (to treat, enhance, repair, remodel, or replace body tissue functions) or diagnostic materials. Biomaterials such as hydrogel implants have been found to be useful for embolization, drug delivery, seal formation, filling, and occlusion purposes. Hydrogels are high water content polymer chains or networks that can absorb large amounts of water and can have tunable mechanical properties. Biomaterials are often injectable into the body, for example, by needles and / or catheters. Upon injection, the material may gel or crosslink to form the implant. However, many known systems deliver multiple components into the body, which then crosslink in vivo after delivery. Thus, the formation of the delivered hydrogel may depend on the conditions in vivo. Thus, in these known methods, the patient may come into contact with both the underlying components (i.e., the monomers or macromers that form the delivered hydrogel) and the delivered hydrogel itself. Such known methods may also require additional stimulation after delivery into the body to promote hydrogel formation. Such additional steps may result in longer procedures and increased variability of the procedure (i.e., from patient to patient).
[0004] Some known systems and methods include the injection and / or implantation of biomaterial products (e.g., hydrogels) into small areas, such as the lumen of a blood vessel or tube. For example, in some applications, the biomaterial forms an implant that acts as an occlusion or embolization of the lumen. Occlusion can be used to provide contraception to a subject by occluding the vas deferens, fallopian tube(s), or uterus. Such occlusion can be used to occlude any other body part, such as a tube, tissue, interstitial space, or organ, for example, for drug delivery, spacing, seal formation, embolization, or bulk. However, known delivery systems do not provide the desired safety, accuracy, precision, and / or reproducibility, especially when small volumes are involved. For example, some known delivery systems and methods are specifically designed to provide a spray (e.g., for wound healing, etc.), because precise control of the total amount delivered, timing of delivery, speed of delivery, and / or force of delivery are rarely of significant concern for such applications. Such known systems are not suitable for applications where it is desired to deliver small, precise amounts to a specific location.
[0005] Some known systems include manual delivery devices, such as syringes that are manually operated to deliver the components. However, such manual systems can often result in high variability. For example, the manual force applied by the physician to the manual delivery device can vary from procedure to procedure, and these variations are magnified when considering that different physicians perform delivery procedures on different patients under different operating conditions. Variations in the manual force applied to known manual delivery devices can significantly affect the total delivery volume administered to the patient and / or to a particular target area, especially when the desired volume of the composition is very small (e.g., 0.001 mL to 1 mL). Insufficient delivery of the composition may result in the target area not being properly occluded, embolized, or sealed, resulting in a failed procedure. On the other hand, excessive delivery of the composition may lead to undesired occlusion, embolization, or seal formation in non-target areas, which can be problematic when the non-target areas are sensitive to the composition or need to remain free of occlusion, embolization, or seal formation. Excessive delivery of the composition may also result in a delivered volume that is ultimately greater than the capacity of the target area, resulting in damage. For example, if the volume of the composition delivered exceeds the capacity of the target vessel, the target vessel may rupture or the tissue may undergo a histological reaction.
[0006] Some known delivery systems include electromechanical delivery mechanisms and therefore do not rely on the practitioner to generate the delivery force and control the timing and delivery process. For example, high pressure jet injectors have been used to deliver highly viscous materials, such as liquids and powders, into the body for drug delivery (see Nora C Hogan, Andrew J Taberner, Lynette A Jones & Ian W Hunter (2015) Needle-free delivery of macromolecules through the skin using controllable jet injectors, Expert Opinion on Drug Delivery, 12:10, 1637-1648). However, these devices are mostly only applicable for injection into the epidermis and do not have needle or catheter attachments to inject liquids or fluids into other closed areas of the body. Furthermore, they cannot inject already formed gels.
[0007] Moreover, such known electronic systems do not include the desired control over the rate, flow rate, and / or force at which the composition is delivered. Known systems that use energy storage devices (e.g., springs, electromechanical devices, etc.) are designed for large volume delivery (e.g., greater than 1 mL) and may deliver the product with a force that causes damage to the target tissue. For example, high delivery rates or large delivery forces may damage or tear the target tissue, thus affecting the overall safety and efficacy of the product. Such known systems may also deliver the underlying components too quickly, such that the resulting delivered biomaterial product forms in or on the body tissue, rather than within the delivery system.
[0008] Known delivery systems and methods also do not contemplate using a single cartridge for two separate delivery operations, as may be the case for procedures associated with symmetrical portions of a biological structure (i.e., the procedure involves delivery to two target locations). For example, a reproductive health or reconstructive / plastic surgery procedure may require the delivery or implantation of biomaterial to two similar, contralateral, or related locations. Many known systems for delivering biomaterial are single-use devices or cartridges that are not suitable for precisely and controllably performing the delivery of a second microvolume of biomaterial implant delivered from the same cartridge.
[0009] Many known delivery systems and methods include a "priming" operation that prepares the components for delivery by removing dead volumes, expelling unwanted air, and the like. Many known systems and methods include performing such priming operations on a delivery member (e.g., a needle) that is attached to the delivery device to remove excess air or fluid from the system prior to delivery. However, such known methods are not applicable when the components are formulated to react within the delivery member within a short period of time during delivery (i.e., to ensure that the delivered biomaterial product is formed upon delivery). For example, conventional priming methods may result in undesired reactions that plug or otherwise damage the delivery member prior to the actual delivery step. Also, such known methods and devices do not support or contemplate a procedure using a single cartridge to perform a second priming function, as described above, where two separate delivery operations are desired.
[0010] Moreover, such known priming systems and methods do not accommodate a method for delivering a priming fluid into a specific target location immediately prior to delivery of a biomaterial product. In particular, known priming methods often aim to exclude air or other fluids and therefore do not allow for delivery of a priming fluid. By delivering a priming fluid with a different echogenicity than the biomaterial, monitoring and tracking of the biomaterial during the procedure can be improved. The priming fluid can also include other properties to prepare the target site for delivery of the biomaterial (e.g., pressurize, lubricate, cleanse, sterilize, aid in cross-linking).
[0011] Therefore, there is a need for devices and methods for delivering biomaterials for medical procedures where control of the rate and volume of biomaterial is desired. More specifically, there is a need for devices and methods for controlled delivery of formed hydrogels to target sites in the body where controlled microvolumes are desired (e.g., 0.001 mL to 1 mL in volume, or 1 μL to 1,000 μL). There is also a need to control the delivery rate and total amount of hydrogel delivered to the target site to prevent or minimize damage to the target site and ensure that the amount delivered is safe and effective against occlusion or embolization of the target site. There is a device and method for applying a controlled automated or semi-automated delivery force to replace the inconsistent hand force currently applied to manual delivery devices. There is further a need for devices and methods that support two separate delivery operations in a single procedure from a single cartridge of hydrogel-forming components. There is also a need to deliver a priming fluid prior to delivery of the formed hydrogel. [Prior art documents] [Patent documents]
[0012] [Patent Document 1] U.S. Provisional Patent Application No. 62 / 760,650 [Non-patent literature]
[0013] [Non-Patent Document 1] Nora C Hogan, Andrew J Taberner, Lynette A Jones & Ian W Hunter (2015), Needle-free delivery of macromolecules through the skin using controllable jet injectors, Expert Opinion on Drug Delivery, 12:10, 1637~1648 Summary of the Invention
[0014] Described herein is a delivery device for forming and delivering a biomaterial from two components. In particular, the devices and methods are described for controlled delivery of a biomaterial into or onto a body part, such as a body lumen. More specifically, in some embodiments, the devices and methods are directed to controlled delivery of microvolumes, defined as volumes between 0.001 mL and 1 mL (or 1 μL and 1,000 μL) (mL and cc are used interchangeably). However, one skilled in the art will appreciate that the devices and methods may be used to effect controlled delivery of volumes greater than 1,000 μL.
[0015] In some embodiments, the device includes a cover and a drive assembly. The cover is configured to receive at least a portion of the container assembly. The container assembly includes a first container containing a first component, a second container containing a second component, a first plunger, and a second plunger. The first and second containers are configured to couple to the connector. The drive assembly is configured to couple to the container assembly. The drive assembly is configured to move the first plunger in the first container to carry a portion of the first component from the first container and move the second plunger in the second container to carry a portion of the second component from the second container. The drive assembly is configured to move the first plunger and the second plunger simultaneously over a period of time to dispense a portion of the first component and a portion of the second component from the connector at an exit rate within a predetermined rate range over the period of time.
[0016] In some embodiments, the device includes a cover, a drive assembly, and an electronic control system. The cover is configured to receive at least a portion of the container assembly. The container assembly is configured to couple to the connector. The container assembly contains a first component and a second component, the first component being separate from the second component within the container assembly. The first component is formulated to crosslink with the second component to form a hydrogel. The drive assembly includes an electromechanical drive and a drive member. The electromechanical drive is configured to generate a drive force to move the drive member. The drive member is configured to engage the container assembly such that movement of the drive member conveys a portion of the first component and a portion of the second component from the container assembly to the connector. The electronic control system includes a sensor and a drive module. The sensor is configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or the drive force. The drive module is implemented in at least one of a memory or a processing device of the electronic control system. A drive module is configured to receive the feedback signal and generate a drive signal based on the feedback signal to maintain the drive force below a drive force threshold.
[0017] In some embodiments, the device includes a cover, a drive assembly, and an electronic control system. The cover is configured to receive at least a portion of the container assembly. The container assembly is configured to couple to the connector. The container assembly contains a first component and a second component, the first component being separate from the second component within the container assembly. The first component is formulated to crosslink with the second component to form a hydrogel. The drive assembly includes an electromechanical drive and a drive member. The electromechanical drive is configured to generate a drive force to move the drive member. The drive member is configured to operably couple to the container assembly such that movement of the drive member conveys a portion of the first component and a portion of the second component from the container assembly to the connector. The electronic control system includes a sensor and a drive module. The sensor is configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or the drive force. The drive module is implemented in at least one of a memory or a processing device of the electronic control system. A drive module is configured to receive the feedback signal and generate a drive signal based on the feedback signal to maintain a speed of the drive member within a predetermined speed range.
[0018] In some embodiments, the device includes a housing, a drive assembly, and an electronic control system. The housing is configured to receive at least a portion of the container assembly. The container assembly includes a first container containing a first component and a second container containing a second component. The first container and the second container are configured to couple to the connector. The drive assembly includes a drive and a drive member. The drive is configured to generate a drive force to move the drive member. The drive member is configured to operably couple to the first plunger and the second plunger such that movement of the drive member moves the first plunger into the first container to carry a portion of the first component from the first container and moves the second plunger into the second container to carry a portion of the second component from the second container. The electronic control system is within the housing. The electronic control system includes a first user input, a second user input, and a drive module. The drive module is implemented in at least one of the memory or processing device of the electronic control system. The drive module is configured to generate a priming signal to move the drive member a priming distance when a first user input is provided. The drive module is configured to generate an injection signal to move the drive member a injection distance when a second user input is provided. The injection distance is associated with a predetermined delivery amount of the first component and the second component.
[0019] In some embodiments, the apparatus includes a first syringe assembly, a second syringe assembly, and a cartridge. The first syringe assembly includes a first syringe body and a first plunger movably disposed within the first syringe body. The first syringe body includes a first flange. The second syringe assembly includes a second syringe body and a second plunger movably disposed within the second syringe body. The second syringe body includes a second flange. The cartridge is configured to removably couple to a delivery device. The delivery device includes a drive assembly configured to move the first plunger within the first syringe body to carry the first component from the first syringe body and move the second plunger within the second syringe body to carry a portion of the second component from the second syringe body. The cartridge defines a flange groove and includes a first retainer, a second retainer, and an engagement portion. The first retainer is configured to hold a first syringe body to the cartridge. The second retainer is configured to hold a second syringe body to the cartridge. The flange groove is configured to receive the first flange and the second flange. The engagement portion is configured to engage the retainer of the delivery device to couple the cartridge to the delivery device in a fixed position relative to a home position associated with the drive assembly.
[0020] In some embodiments, a method of delivering a composition includes coupling an inlet of a connector to a container assembly. The container assembly includes a first component and a second component separate from the first component. The method includes priming the connector by conveying a first portion of the first component from the container assembly to a first outlet of the connector and a first portion of the second component from the container assembly to a second outlet of the connector. The method includes coupling a delivery member to the connector to place the first outlet of the connector and the second outlet of the connector in fluid communication with a mixing volume defined by the delivery member after priming. The method includes conveying a second portion of the first component and a second portion of the second component into the mixing volume after coupling of the delivery member. The second portion of the first component crosslinks with the second portion of the second component to form a hydrogel within the delivery member. The method includes conveying the hydrogel from the delivery member through the outlet portion of the delivery member.
[0021] In some embodiments, a method of delivering a composition includes coupling a container assembly to a delivery device. The container assembly includes a first component and a second component separate from the first component. The delivery device includes a drive assembly. The method includes inserting a first delivery member into a first body lumen. The method includes coupling the first delivery member to the container assembly after inserting the first delivery member. The method includes actuating the delivery device to generate a first drive force by the drive assembly to convey a first portion of the first component and a first portion of the second component from the container assembly through the first delivery member. The first component crosslinks with the second component to form a first hydrogel within the first delivery member, and the first hydrogel is conveyed into the first body lumen. The method includes decoupling the first delivery member from the container assembly after actuation. The method includes inserting a second delivery member into the second body lumen. The method includes coupling the second delivery member to the container assembly after inserting the second delivery member. The method includes generating a second driving force by the drive assembly to actuate the delivery device to convey a second portion of the first component and a second portion of the second component from the container assembly through the second delivery member. The first component crosslinks with the second component to form a second hydrogel within the second delivery member, and the second hydrogel is conveyed into the second body lumen.
[0022] In some embodiments, a method of delivering a composition to a body lumen within a body includes inserting an outlet portion of a delivery member into the body lumen. The connecting portion of the delivery member is outside the body. The method includes connecting a container assembly to the connecting portion of the delivery member after insertion. The container assembly includes a first component and a second component. The connecting is performed to hold a bolus of air within at least a portion of the delivery member. The method includes conveying the first component and the second component into the delivery member. The first component crosslinks with the second component to form a hydrogel within the delivery member. Conveying the first component and the second component into the delivery member causes the bolus of air to be delivered into the body lumen through the outlet portion of the delivery member. The method includes conveying the hydrogel into the body lumen through the outlet portion of the delivery member after conveying the first component and the second component into the delivery member.
[0023] In some embodiments, a method of delivering a composition includes conveying a first component stored in a first chamber of a container assembly to a first inlet of a connector coupled to the container assembly. The method includes conveying a second component stored in a second chamber of the container assembly to a second inlet portion of the connector. The method includes conveying the first and second components through the delivery member, through an outlet portion of the connector, and into a mixing volume of the delivery member. The delivery member removably couples to the connector. The first component crosslinks with the second component to form a hydrogel within the delivery member such that conveying the first and second components through the outlet portion causes the hydrogel to be conveyed out of the outflow opening of the delivery member.
[0024] The following description and accompanying drawings provide further details about various systems, methods, and devices for delivering biomaterials. [Brief description of the drawings]
[0025] [Figure 1] 1 is a schematic diagram of a portion of a delivery system, according to an embodiment. [Diagram 2] 1 is a schematic diagram of a portion of a delivery system, according to an embodiment. [Diagram 3] 3 is a plot showing velocity profiles of sample biomaterial components during use of the delivery system of FIG. 2. [Figure 4] 3 is a plot showing velocity profiles of sample biomaterial components during use of the delivery system of FIG. 2. [Diagram 5] 3 is a schematic diagram of a portion of the delivery system shown in FIGS. 1 and 2 inserted into a body lumen, according to an embodiment. FIG. [Figure 6] FIG. 6 is a schematic diagram of the delivery system of FIG. 5 for delivering a biomaterial component to a body lumen. [Figure 7] 6 is a schematic diagram of a biomaterial component disposed within a body lumen after the delivery system of FIG. 5 has been withdrawn from the body lumen. [Figure 8] FIG. 1 is a schematic diagram of a delivery system including a body, a connector, a drive assembly, and an electronic control system, according to an embodiment. [Figure 9] FIG. 9 is a schematic diagram of the delivery system in FIG. 8 with the connector connected to the body. [Figure 10] 10 is a plot showing the force profile of a sample biomaterial component during use of the delivery system of FIG. 9. [Figure 11] 1 is a flow diagram of a method of conveying first and second components from a container assembly to form a hydrogel, according to an embodiment. [Figure 12] FIG. 2 is a schematic diagram showing a side view of a delivery device, according to an embodiment. [Figure 13] FIG. 13 is a schematic diagram showing a cross-sectional side view of the delivery device of FIG. [Figure 14] FIG. 13 is a schematic diagram showing a cross-sectional top view of the delivery device of FIG. [Figure 15] 1A-1C are schematic diagrams of a container illustrating various operating positions and travel distances of a plunger of a delivery device, according to an embodiment. [Figure 16] FIG. 2 is a top view of a portion of a delivery system, according to an embodiment. [Figure 17] FIG. 17 is a side cross-sectional view of the delivery system of FIG. [Figure 18] FIG. 13 is an exploded view of a container assembly and a connector, according to an embodiment. [Figure 19] 19 is a perspective view of the connector of FIG. 18 showing a coupler for releasably connecting to a delivery member. [Figure 20] FIG. 20 is a perspective view of the connector of FIG. 19 with the coupler removed. [Figure 21] 19 is a top view of a portion of a cartridge for carrying the container assembly of the delivery system shown in FIG. 18. [Figure 22] 22 is a top view of the container assembly and connector of FIG. 18 mounted on the cartridge of FIG. 21. [Diagram 23] 23 is a side cross-sectional view of the cartridge, container assembly, and connector of FIG. 22 mounted onto the delivery system of FIG. 17. [Figure 24] 23 is a side cross-sectional view of the cartridge, container assembly, and connector of FIG. 22 mounted onto the delivery system of FIG. 17. [Diagram 25] 18 is a side cross-sectional view of a cartridge, container assembly, and connector mounted onto the delivery system of FIG. 17. [Figure 26] FIG. 18 is a top view of the cartridge, container assembly, and connector mounted onto the delivery system of FIG. 17. [Figure 27] FIG. 13 is a perspective view of a connector and a delivery member, according to an embodiment. [Figure 28] 18 is a perspective view of a delivery member mounted onto a connector of the delivery system of FIG. 17, according to an embodiment. [Figure 29] FIG. 29 is a side cross-sectional view of the delivery system of FIG. 28 after delivery of a component from the container assembly. [Diagram 30] FIG. 29 is a top view of the delivery system of FIG. 28 after delivery of the components from the container assembly. [Diagram 31] 30 is a partial cross-sectional side view of the cartridge, container assembly, and connector in the delivery system of FIG. 28 after removal from the delivery device. [Diagram 32] 1 is a flow diagram of a method for delivering a hydrogel, according to an embodiment. [Diagram 33]1 is a flow diagram of a method for delivering a hydrogel, according to an embodiment. [Diagram 34] 1 is a schematic diagram illustrating insertion of a delivery member into a body lumen, according to an embodiment. [Diagram 35] 35 is a schematic diagram illustrating the connection of the delivery member of FIG. 34 to a connector attached to a container assembly, according to an embodiment. [Diagram 36] FIG. 36 is a schematic diagram illustrating the delivery of a biomaterial component to a body lumen via the connector and delivery member of FIG. 35. [Figure 37] 1 is a flow diagram of a method for delivering a hydrogel into a body lumen, according to an embodiment. [Figure 38] 38-39 are partial cross-sectional views of the vas deferens and its internal body lumen at various stages during the method shown in FIG. 37. [Figure 39] 38-39 are partial cross-sectional views of the vas deferens and its internal body lumen at various stages during the method shown in FIG. 37. [Diagram 40] 11 is a graph showing the accuracy and precision of plug volumes extruded from an automated delivery device versus plug volumes produced by a discretionary delivery device, according to an embodiment. [Diagram 41] 13 is a graph showing target volume and resulting plug volume using a delivery device according to an embodiment, such as an automated delivery device. [Diagram 42] 11 is a graph showing the length of push-out plugs and fixation plugs formed using a delivery device according to an embodiment, such as an automated delivery device. [Diagram 43] FIG. 2 is a side view of a delivery system, according to an embodiment. [Diagram 44] FIG. 44 is a rear perspective view of the delivery system of FIG. 43 showing a user-operated button. [Diagram 45] FIG. 44 is a front perspective view of the delivery system of FIG. 43 showing the cover in an open position. [Diagram 46] FIG. 44 is an orthographic view of the delivery system of FIG. [Figure 47] FIG. 2 is a side view of a delivery system, according to an embodiment. [Figure 48]FIG. 48 is a rear perspective view of the delivery system of FIG. 47 showing a user-operated button. [Figure 49] FIG. 48 is a front perspective view of the delivery system of FIG. 47 showing the container assembly detached from the cover. [Figure 50A] FIG. 48 is a front perspective view of the delivery system of FIG. 47 showing the container assembly secured to the cover. [Figure 50B] FIG. 48 is a rear perspective view of the delivery system of FIG. 47 showing the container assembly secured to the cover. [Figure 51A] FIG. 48 is a front perspective view of the delivery system of FIG. 47 showing the container assembly secured to the cover. [Figure 51B] FIG. 48 is a rear perspective view of the delivery system of FIG. [Figure 52] FIG. 48 is an orthographic view of the delivery system of FIG. [Figure 53] FIG. 2 is a side view of a delivery system, according to an embodiment. [Figure 54] FIG. 54 is a rear perspective view of the delivery system of FIG. 53, showing the power button and status indicators. [Figure 55] FIG. 54 is a front perspective view of the delivery system of FIG. 53 showing the container assembly detached from the cover. [Figure 56] FIG. 54 is an orthographic view of the delivery system of FIG. 53. [Figure 57] FIG. 1 is a cross-sectional view of a normal dog vas deferens. [Figure 58] FIG. 1 shows a cross-sectional view of a dog's vas deferens after an injection event. [Figure 59] 13 is an external image of a dog's vas deferens following an injection event. [Figure 60] 13 is an external image of a rabbit's vas deferens after an injection event. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] In some embodiments, the device includes a cover and a drive assembly. The cover is configured to receive at least a portion of the container assembly. The container assembly includes a first container containing a first component, a second container containing a second component, a first plunger, and a second plunger. The first and second containers are configured to couple to the connector. The drive assembly is configured to couple to the container assembly. The drive assembly is configured to move the first plunger in the first container to carry a portion of the first component from the first container and move the second plunger in the second container to carry a portion of the second component from the second container. The drive assembly is configured to move the first plunger and the second plunger simultaneously over a period of time to dispense a portion of the first component and a portion of the second component from the connector at an exit rate within a predetermined rate range over the period of time.
[0027] In some embodiments, the predetermined speed range is bounded by an upper speed threshold and a lower speed threshold. In some embodiments, the upper speed threshold and the lower speed threshold are such that the delivery volume of the portion of the first component and the portion of the second component is within the delivery volume range. In some embodiments, the delivery range is between about 5 microliters and about 1000 microliters. In some embodiments, the lower speed threshold is greater than zero.
[0028] In some embodiments, the drive assembly includes an electromechanical drive, a drive member, and an electronic control system. The drive member is configured to engage the plunger assembly, and movement of the drive member is configured to move the first plunger and the second plunger. The electromechanical drive is configured to generate a drive force to move the drive member. The electronic control system is configured to control the drive member speed to maintain the outflow rate within a predetermined speed range over time.
[0029] In some embodiments, the electronic control system includes a sensor and a drive module. The sensor is configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or a drive force applied via the drive member. The drive module is implemented in at least one of a memory or processing device of the electronic control system. The drive module is configured to receive the feedback signal and generate a drive signal that adjusts the power applied to the electromechanical drive based on the feedback signal. In some embodiments, the electronic control system is configured to maintain the drive force applied by the drive member on the plunger assembly below a force threshold. In some embodiments, the drive module is configured to generate an error signal when the power applied to the electromechanical drive exceeds a power threshold. In some embodiments, the force threshold is between about 0.1 Newtons and about 45 Newtons.
[0030] In some embodiments, the drive assembly includes at least one of a linear motor drive system, a screw drive system, a magnetic linear drive system, a rack and pinion drive system, or a pneumatic drive system. In some embodiments, the drive assembly includes an anti-backlash mechanism. The anti-backlash mechanism includes one or more of an anti-backlash gear, a selectively engageable spring mechanism, a damper mechanism, or a ratchet mechanism.
[0031] In some embodiments, the container assembly includes a cartridge including an engagement portion. The cartridge is configured to couple to the first container and the second container. The cover includes a container portion configured to receive the cartridge. The container portion includes a retainer configured to engage the engagement portion of the cartridge to removably hold the cartridge and container assembly in the container portion of the cover in a fixed position relative to a home position associated with the drive assembly. In some embodiments, the engagement portion of the cartridge is the first engagement portion. The cartridge including the second engagement portion of the container portion and the retainer is the first retainer. The container portion includes a second retainer configured to engage the second engagement portion of the cartridge to prevent movement of the container assembly relative to the cover in at least two directions. In some embodiments, at least one of the first retainer, the first engagement portion, the second retainer, or the second engagement portion is configured to deform to allow the cartridge to be removed from the container portion of the cover. In some embodiments, the container portion of the cover defines a container volume that receives the cartridge. The device further includes a cover. The cover is configured to move relative to the enclosure between a first position and a second position, such that when the cover is in the first position, a volume of the container is covered and when the cover is in the second position, the volume of the container is exposed.
[0032] In some embodiments, the first component and the second component are each water-soluble components. In some embodiments, the first component and the second component can be crosslinked to form a hydrogel. In some embodiments, the hydrogel formed by crosslinking the first component and the second component is at least 90 percent water. In some embodiments, the first component is characterized by having a first viscosity. The second component is characterized by a second viscosity, the second viscosity being within 25 percent of the first viscosity. In some embodiments, the hydrogel formed by crosslinking the first component and the second component has a gelation time of less than 5 minutes.
[0033] In some embodiments, the device includes a cover, a drive assembly, and an electronic control system. The cover is configured to receive at least a portion of the container assembly. The container assembly is configured to couple to the connector. The container assembly contains a first component and a second component, the first component being separate from the second component within the container assembly. The first component is formulated to crosslink with the second component to form a hydrogel. The drive assembly includes an electromechanical drive and a drive member. The electromechanical drive is configured to generate a drive force to move the drive member. The drive member is configured to engage the container assembly such that movement of the drive member conveys a portion of the first component and a portion of the second component from the container assembly to the connector. The electronic control system includes a sensor and a drive module. The sensor is configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or the drive force. The drive module is implemented in at least one of a memory or a processing device of the electronic control system. A drive module is configured to receive the feedback signal and generate a drive signal based on the feedback signal to maintain the drive force below a drive force threshold.
[0034] In some embodiments, the container assembly includes at least one container that contains at least one of the first component or the second component. The container includes an elastomeric member to seal the first component or the second component within the container. The drive member is configured to move the elastomeric member within the container to convey at least one of a portion of the first component or a portion of the second component to the connector. The electromechanical drive is configured to generate a breakaway force over a first time period to initiate movement of the elastomeric member within the container. The drive force is generated over a second time period after the first time period. In some embodiments, the drive module is configured to generate a drive signal based on the feedback signal to maintain the breakaway force below a breakaway force threshold and the drive force below a drive force threshold. In some embodiments, the drive module is configured to generate a drive signal to maintain a speed of the drive member within a predetermined speed range during the second time period. In some embodiments, the drive module is configured to generate a completion signal to remove power applied to the electromechanical drive.
[0035] In some embodiments, the drive module is configured to generate an error signal when the drive force exceeds a drive force threshold. In some embodiments, the electronic control system includes an output device. The error signal causes the output device to generate at least one of a visual, an audible, or a tactile output. Additionally, the error signal causes a reduction in power applied to the electro-mechanical drive.
[0036] In some embodiments, the threshold drive force is between about 7 Newtons and about 12 Newtons. In some embodiments, the sensor is configured to measure at least one of a current or a voltage supplied to the electromechanical drive. The drive module is configured to determine the drive force based on the current or the voltage supplied to the electromechanical drive. The drive module is configured to generate a drive signal to regulate the current or the voltage.
[0037] In some embodiments, the sensor is a first sensor, the feedback signal is a first feedback signal, and the drive force threshold is a first drive force threshold. The electronic control system includes a second sensor configured to generate a second feedback signal indicative of whether the connector is coupled to the container assembly. The drive module is configured to generate a drive signal to maintain the drive force below the first drive force threshold when the second feedback signal indicates that the connector is not coupled to the container assembly and below the second drive force threshold when the second feedback signal indicates that the connector is coupled to the container assembly. In some embodiments, the device includes a connector. The connector is any one of an adaptor, a y-connector, or a connector of the delivery member.
[0038] In some embodiments, the device includes a cover, a drive assembly, and an electronic control system. The cover is configured to receive at least a portion of the container assembly. The container assembly is configured to couple to the connector. The container assembly contains a first component and a second component, the first component being separate from the second component within the container assembly. The first component is formulated to crosslink with the second component to form a hydrogel. The drive assembly includes an electromechanical drive and a drive member. The electromechanical drive is configured to generate a drive force to move the drive member. The drive member is configured to operably couple to the container assembly such that movement of the drive member conveys a portion of the first component and a portion of the second component from the container assembly to the connector. The electronic control system includes a sensor and a drive module. The sensor is configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or the drive force. The drive module is implemented in at least one of a memory or a processing device of the electronic control system. A drive module is configured to receive the feedback signal and generate a drive signal based on the feedback signal to maintain the speed of the drive member within a predetermined speed range, hi some embodiments, the drive module is configured to generate the drive signal to adjust one of a current or a voltage applied to the electro-mechanical drive.
[0039] In some embodiments, the device includes a housing, a drive assembly, and an electronic control system. The housing is configured to receive at least a portion of the container assembly. The container assembly includes a first container containing a first component and a second container containing a second component. The first container and the second container are configured to couple to the connector. The drive assembly includes a drive and a drive member. The drive is configured to generate a drive force to move the drive member. The drive member is configured to operably couple to the first plunger and the second plunger such that movement of the drive member moves the first plunger into the first container to carry a portion of the first component from the first container and moves the second plunger into the second container to carry a portion of the second component from the second container. The electronic control system is within the housing. The electronic control system includes a first user input, a second user input, and a drive module. The drive module is implemented in at least one of the memory or processing device of the electronic control system. The drive module is configured to generate a priming signal to move the drive member a priming distance when a first user input is provided. The drive module is configured to generate an injection signal to move the drive member a injection distance when a second user input is provided. The injection distance is associated with a predetermined delivery amount of the first component and the second component.
[0040] In some embodiments, the electronic control system includes an output device. The drive module is configured to generate an error signal under a condition that the first user input is not provided and the second user input is provided. The error signal causes the output device to generate one of a visual, an audible, or a tactile output. In some embodiments, the error signal disables the injection signal.
[0041] In some embodiments, the electronic control system includes a sensor and an output device. The sensor is configured to generate a feedback signal indicating whether the connector is coupled to the container assembly. The drive module is configured to generate an error signal when the feedback signal indicates that the connector is not coupled to the container assembly. The error signal causes the output device to generate one of a visual, an audible, or a tactile output. In some embodiments, the error signal disables at least one of the priming signal or the injecting signal.
[0042] In some embodiments, the priming signal is a first priming signal and the priming distance is a first priming distance. The drive module is configured to generate the first priming signal when the first user input is provided a first time to move the drive member a first priming distance. The drive module is configured to generate a second priming signal when the first user input is provided a second time to move the drive member a second priming distance, the second priming distance being different from the first priming distance.
[0043] In some embodiments, the electronic control system includes a sensor configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or a drive force, and the drive module is configured to receive the feedback signal and adjust the injection signal based on the feedback signal to maintain the velocity of the drive member within a predetermined speed range.
[0044] In some embodiments, the electronic control system includes a sensor configured to generate a feedback signal associated with at least one of a position of the drive member, a velocity of the drive member, an acceleration of the drive member, or the drive force, and the drive module is configured to receive the feedback signal and adjust the injection signal based on the feedback signal to maintain the drive force below a threshold drive force.
[0045] In some embodiments, the apparatus includes a first syringe assembly, a second syringe assembly, and a cartridge. The first syringe assembly includes a first syringe body and a first plunger movably disposed within the first syringe body. The first syringe body includes a first flange. The second syringe assembly includes a second syringe body and a second plunger movably disposed within the second syringe body. The second syringe body includes a second flange. The cartridge is configured to removably couple to a delivery device. The delivery device includes a drive assembly configured to move the first plunger within the first syringe body to carry the first component from the first syringe body and move the second plunger within the second syringe body to carry a portion of the second component from the second syringe body. The cartridge defines a flange groove and includes a first retainer, a second retainer, and an engagement portion. The first retainer is configured to hold a first syringe body to the cartridge. The second retainer is configured to hold a second syringe body to the cartridge. The flange groove is configured to receive the first flange and the second flange. The engagement portion is configured to engage the retainer of the delivery device to couple the cartridge to the delivery device in a fixed position relative to a home position associated with the drive assembly.
[0046] In some embodiments, the retainer of the delivery device is a first retainer and the engagement portion of the cartridge is a first engagement portion. The cartridge includes a second engagement portion configured to engage a second retainer of the delivery device to prevent movement of the cartridge relative to the delivery device. In some embodiments, the apparatus further includes a plunger link configured to couple to an end of the first plunger and an end of the second plunger. The plunger link includes a contact surface that applies a driving force such that a drive assembly of the delivery device moves the first plunger in the first syringe body and the second plunger in the second syringe body. In some embodiments, the apparatus further includes a connector having a first inlet, a second inlet, and an outlet. The first inlet is configured to couple to a tip of the first syringe body. The second inlet is configured to couple to a tip of the second syringe body. The outlet of the connector is configured to removably couple to a delivery member.
[0047] In some embodiments, a method of delivering a composition includes coupling an inlet of a connector to a container assembly. The container assembly includes a first component and a second component separate from the first component. The method includes priming the connector by conveying a first portion of the first component from the container assembly to a first outlet of the connector and a first portion of the second component from the container assembly to a second outlet of the connector. The method includes coupling a delivery member to the connector to place the first outlet of the connector and the second outlet of the connector in fluid communication with a mixing volume defined by the delivery member after priming. The method includes conveying a second portion of the first component and a second portion of the second component into the mixing volume after coupling of the delivery member. The second portion of the first component crosslinks with the second portion of the second component to form a hydrogel within the delivery member. The method includes conveying the hydrogel from the delivery member through the outlet portion of the delivery member.
[0048] In some embodiments, the container assembly includes a first container containing the first component and a second container containing the second component, the second container being separate from the first container, and coupling the inlet of the connector to the container assembly includes connecting a first inlet of the connector to the first container and a second inlet of the connector to the second container.
[0049] In some embodiments, the delivery member is a first delivery member and the hydrogel is a first hydrogel. The method includes removing the first delivery member from the connector. The method includes priming the connector by conveying a third portion of the first component to a first outlet of the connector and conveying a third portion of the second component to a second outlet of the connector after removing the first delivery member. The method includes coupling the second delivery member to the connector to place the first outlet and the second outlet in fluid communication with a second mixing volume defined by the second delivery member. The method includes conveying a fourth portion of the first component and a fourth portion of the second component to the second mixing volume, where the fourth portion of the first component crosslinks with the fourth portion of the second component to form a hydrogel in the second mixing volume. In some embodiments, the delivery member is one of a catheter, a needle, or an over-the-needle catheter.
[0050] In some embodiments, the method includes delivering the second hydrogel from the second delivery member through an outlet portion of the second delivery member. In some embodiments, delivering the first hydrogel from the first delivery member includes delivering the hydrogel to a first body lumen. Delivering the second hydrogel from the second delivery member includes delivering the hydrogel to a second body lumen, the second body lumen being different from the first body lumen.
[0051] In some embodiments, conveying the hydrogel from the delivery member comprises conveying the hydrogel to a body lumen. In some embodiments, the body lumen is one of an artery, a vein, a capillary, a blood vessel, a tissue, an intraorgan space, a lymphatic vessel, a duct of sperm, an epididymis, a fallopian tube, a duct, a bile duct, a hepatic duct, a gall bladder duct, a pancreatic duct, a parotid duct, an organ, a uterus, a prostate, a gastrointestinal tract, or an organ of the circulatory system, or of the respiratory system, or of the nervous system, a subcutaneous space, an intramuscular space, or an interstitial space. In some embodiments, the hydrogel conveyed to the body lumen at least partially occludes the body lumen. In some embodiments, conveying the hydrogel from the delivery member occurs in less than 30 seconds. In some embodiments, conveying the hydrogel from the delivery member comprises conveying about 50 microliters to about 200 microliters in between about 5 seconds and about 20 seconds.
[0052] In some embodiments, conveying the second portion of the first component and the second portion of the second component to the mixing volume of the delivery member comprises conveying equal amounts of the second portion of the first component and the second portion of the second component.
[0053] In some embodiments, conveying the second portion of the first component and the second portion of the second component into the mixing volume of the delivery member is performed by an electromechanical drive of a drive assembly of the delivery device. In some embodiments, the delivery device includes an electronic control system. Conveying the hydrogel from the delivery member includes generating a drive signal by the electronic control system that controls the electromechanical drive to maintain an outflow force of the hydrogel conveyed from the delivery member below a flow force threshold. In some embodiments, the delivery device includes an electronic control system. Conveying the hydrogel from the delivery member is performed over a period of time to generate a delivery volume of hydrogel. Conveying the second portion of the first component and the second portion of the second component into the mixing volume and conveying the hydrogel from the delivery member includes generating a drive signal by the electronic control system that controls the electromechanical drive to maintain a velocity of the hydrogel in the delivery member within a predetermined velocity range over a period of time. In some embodiments, priming the connector includes providing energy to the electromechanical drive to actuate a plunger assembly that couples to the container assembly.
[0054] In some embodiments, the coupling of the delivery member is performed such that a bolus of air is in the mixing volume. Conveying the hydrogel from the delivery member includes delivering the hydrogel to the body lumen. Conveying a second portion of the first component and a second portion of the second component into the mixing volume delivers a bolus of air into the body lumen before the hydrogel is delivered to the body lumen. In some embodiments, the coupling of the delivery member is performed such that a bolus of air is in the mixing volume. Conveying the hydrogel from the delivery member includes delivering the hydrogel to the body lumen. Conveying a second portion of the first component and a second portion of the second component into the mixing volume delivers a bolus of air into the body lumen before the hydrogel is delivered to the body lumen. In some embodiments, the coupling of the delivery member is performed such that a bolus of air is in the mixing volume. Conveying the hydrogel from the delivery member includes delivering the hydrogel to the body lumen. A bolus of air is delivered into the body lumen by delivering a second portion of the first component and a second portion of the second component into the mixing volume before the hydrogel is delivered to the body lumen, hi some embodiments, the second portion of the first component crosslinks with said second portion of the second component to form a hydrogel in less than 60 seconds.
[0055] In some embodiments, a method of delivering a composition includes coupling a container assembly to a delivery device. The container assembly includes a first component and a second component separate from the first component. The delivery device includes a drive assembly. The method includes inserting a first delivery member into a first body lumen. The method includes coupling the first delivery member to the container assembly after inserting the first delivery member. The method includes actuating the delivery device to generate a first drive force by the drive assembly to convey a first portion of the first component and a first portion of the second component from the container assembly through the first delivery member. The first component crosslinks with the second component to form a first hydrogel within the first delivery member, and the first hydrogel is conveyed into the first body lumen. The method includes decoupling the first delivery member from the container assembly after actuation. The method includes inserting a second delivery member into the second body lumen. The method includes coupling the second delivery member to the container assembly after inserting the second delivery member. The method includes generating a second driving force by the drive assembly to actuate the delivery device to convey a second portion of the first component and a second portion of the second component from the container assembly through the second delivery member. The first component crosslinks with the second component to form a second hydrogel within the second delivery member, and the second hydrogel is conveyed into the second body lumen.
[0056] In some embodiments, a method of delivering a composition to a body lumen within a body includes inserting an outlet portion of a delivery member into the body lumen. The connecting portion of the delivery member is outside the body. The method includes connecting a container assembly to the connecting portion of the delivery member after insertion. The container assembly includes a first component and a second component. The connecting is performed to hold a bolus of air within at least a portion of the delivery member. The method includes conveying the first component and the second component into the delivery member. The first component crosslinks with the second component to form a hydrogel within the delivery member. Conveying the first component and the second component into the delivery member causes the bolus of air to be delivered into the body lumen through the outlet portion of the delivery member. The method includes conveying the hydrogel into the body lumen through the outlet portion of the delivery member after conveying the first component and the second component into the delivery member.
[0057] In some embodiments, the bolus of air is selected to have a volume sufficient to expand the body lumen prior to delivery of the hydrogel into the body lumen, hi some embodiments, the selected volume is between 0.1 mL and 10 mL.
[0058] In some embodiments, the hydrogel is echogenic and the method includes identifying the bolus of air by imaging, such as by ultrasound, of the body lumen, in some embodiments, the body lumen is one of an artery, a vein, a capillary, a blood vessel, a tissue, an intraorgan space, a lymphatic vessel, a vas deferens, an epididymis, an fallopian tube, a duct, a bile duct, a hepatic duct, a gall bladder duct, a pancreatic duct, a parotid duct, an organ, a uterus, a prostate, a gastrointestinal tract, or an organ of the circulatory system, or the respiratory system, or the nervous system, a subcutaneous space, an intramuscular space, or an interstitial space.
[0059] In some embodiments, conveying the first and second components into the delivery member is performed by an electromechanical drive of a drive assembly of the delivery device. In some embodiments, the delivery device includes an electronic control system. Conveying the hydrogel into the body lumen includes generating a drive signal by the electronic control system to control the electromechanical drive to maintain an outflow force of the hydrogel conveyed from the delivery member below a threshold outflow force. In some embodiments, the delivery device includes an electronic control system. Conveying the hydrogel into the body lumen is performed over a period of time to generate a delivery volume of hydrogel. Conveying the first and second components into the delivery member and conveying the hydrogel into the body lumen include generating a drive signal by the electronic control system to control the electromechanical drive to maintain a velocity of the hydrogel in the delivery member within a predetermined velocity range over a period of time.
[0060] In some embodiments, the method includes priming an outlet portion of the container assembly by conveying a portion of the first component from the container assembly to a first outlet of the container assembly, and by conveying a portion of the second component from a container of the container assembly to a second outlet of the container assembly, prior to coupling of the container assembly to the coupling portion of the delivery member.
[0061] In some embodiments, a method of delivering a composition includes conveying a first component stored in a first chamber of a container assembly to a first inlet of a connector coupled to the container assembly. The method includes conveying a second component stored in a second chamber of the container assembly to a second inlet portion of the connector. The method includes conveying the first and second components through the delivery member, through an outlet portion of the connector, and into a mixing volume of the delivery member. The delivery member removably couples to the connector. The first component crosslinks with the second component to form a hydrogel within the delivery member such that conveying the first and second components through the outlet portion causes the hydrogel to be conveyed out of the outflow opening of the delivery member.
[0062] In some embodiments, the hydrogel is delivered from the outflow opening of the delivery member into a body lumen to at least partially occlude the body lumen, in some embodiments, the body lumen is one of an artery, a vein, a capillary, a blood vessel, a tissue, an organ space, a lymphatic vessel, a vas deferens, an epididymis, an fallopian tube, a duct, a bile duct, a hepatic duct, a gall bladder duct, a pancreatic duct, a parotid duct, an organ, a uterus, a prostate, a gastrointestinal tract, or an organ of the circulatory system, or the respiratory system, or the nervous system, a subcutaneous space, an intramuscular space, or an interstitial space.
[0063] In some embodiments, conveying the first component and the second component to the mixing volume comprises conveying equal amounts of the first component and the second component.
[0064] In some embodiments, the first and second components are formulated such that the hydrogel has a gelation time. The first and second components are conveyed through the delivery member through the outlet portion into the mixing volume within a flow rate range based on the gelation time such that the hydrogel forms completely within the delivery member before being conveyed out of the outflow opening. In some embodiments, the first and second components are conveyed through the delivery member through the outlet portion into the mixing volume by an electromechanical drive of a drive assembly of the delivery device. The delivery device includes an electronic control system. The conveying of the first and second components through the delivery member through the outlet portion into the mixing volume includes generating a drive signal by the electronic control system that controls the electromechanical drive to maintain a velocity of the hydrogel within the delivery member within a predetermined velocity range. In some embodiments, the conveying of the first and second components through the delivery member through the outlet portion into the mixing volume is performed for a period of time to generate a delivery volume of hydrogel.
[0065] In some embodiments, the first component is polyvinyl alcohol, alginic acid or modified alginic acid, chitosan or modified chitosan, polyethyleneimine, carboxymethylcellulose, or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). The second component is water or a buffer, water or a buffer with a divalent cation such as calcium, a solution of reduced hyaluronic acid, a solution of polystyrene sulfonic acid, a solution of gelatin, or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). In some embodiments, the polyvinyl alcohol, alginic acid, chitosan, polyethyleneimine, carboxymethylcellulose, polyethylene glycol terminated with a functional group, divalent cation, reduced hyaluronic acid, polystyrene sulfonic acid, or gelatin has a weight percentage ranging from about 1 to 30% in the solvent. In some embodiments, the polysaccharide may be modified with different functional groups. In some embodiments, polysaccharides and proteins may range in molecular weight from 10,000 to 1,000,000 grams / mole. In some embodiments, polyvinyl alcohol, polystyrene sulfonate, polyethyleneimine, and polyethylene glycol may be linear, Y-shaped, 3-, 4-, 6-, or 8-armed, and may range in molecular weight from 1,000 to 1,000,000 grams / mole.
[0066] In some embodiments, the injection device includes a device body, one or more syringes, a controller, and one or more input devices. The device body includes a shaft, a handle, and an injection trigger. Each of the one or more syringes includes a plunger operatively connected to one or more actuators disposed within the device body. The controller is operatively connected to the actuators. The one or more input devices are operatively connected to the controller, the input devices capable of priming or injecting fluid within the one or more syringes.
[0067] In some embodiments, the one or more input devices are located on an exterior portion of the device body. In some embodiments, the one or more syringes, the actuator, and the controller are located within the device body. The one or more syringes include two syringes operably connected to the one or more actuators. In some embodiments, the or each plunger is operably connected to the actuator by a piston.
[0068] In some embodiments, the injection device includes a connector that connects to one or more syringes. The connector is a Y-connector that connects to two syringes. The one or more syringes, the actuator, and the controller are disposed within the shaft. In some embodiments, the injection device includes a power source. In some embodiments, the injection device includes a needle hub disposed at the end of the connector. The injection device includes a mixing chamber, optionally disposed between the connector and the needle hub.
[0069] In some embodiments, the actuator is a stepper motor or a torque motor. The injection device can inject microvolumes in the range of 1 μL to 1000 μL. The injection device includes a pressure sensor operatively connected to the controller and capable of being activated by a trigger. The pressure sensor can activate the controller to send a signal to the actuator to drive the piston. In some embodiments, the controller includes a processor and a memory. The memory includes a set of computer readable instructions capable of controlling the speed, acceleration, force, and / or time at which the actuator drives the piston. In some embodiments, the speed, acceleration, force, and / or time at which the actuator drives the piston are programmable. In some embodiments, the injection device includes a user interface capable of programming the injection device, such as the speed, force, and / or time at which the actuator drives the piston.
[0070] In some embodiments, the injection device can add a solvent to the solids in the container to dissolve the solids prior to the injection step. The injection device can degas the liquid. The injection device can deliver different volumes in states such as gas, liquid, gel, and solids such as powder or particulates. The injection device can fix the needle / catheter and replace it from the tip. In some embodiments, the injection device can mix multiple substances in a single container and deliver multiple volumes from the container to the target location.
[0071] The term "about," when used in connection with a reference numerical indication, means the reference numerical indication plus or minus up to 10% of the reference numerical indication. For example, "about 100" means from 90 to 110.
[0072] The term "substantially," when used in connection with, for example, a geometric relationship, a numerical value, and / or a range, is intended to convey that the geometric relationship (or structure described by the geometric relationship), number, and / or range so defined is nominally the recited geometric relationship, number, and / or range. For example, two structures described herein as "substantially parallel" are intended to convey that while a parallel geometric relationship is desired, some non-parallelism may occur in a "substantially parallel" arrangement. As another example, a structure defining a volume that is "substantially 0.50 milliliters (mL)" is intended to convey that while the recited volume is desired, some tolerance may occur when the volume is "substantially" the recited volume (e.g., 0.50 mL). Such tolerances may result from manufacturing tolerances, measurement tolerances, and / or other practical considerations (e.g., minute imperfections, age of the structure so defined, pressures or forces exerted within the system, and / or the like). As noted above, suitable tolerances can be, for example, ±10% of the recited geometries, values, and / or ranges.
[0073] As used herein, the term "biomaterial component" (also referred to as "component") includes any substance used in connection with any of the systems or delivery devices described herein to form a delivered biomaterial product. For example, a component can include a small molecule, a catalyst, a peptide, a protein, an enzyme, a nucleotide (or a derivative thereof), a short chain of nucleotides (or a derivative thereof), a long chain of nucleotides (or a derivative thereof), a monosaccharide (or a derivative thereof), a disaccharide (or a derivative thereof), a trisaccharide (or a derivative thereof), an oligosaccharide (or a derivative thereof), a polysaccharide (or a derivative thereof), a monomer, an oligomer, a macromer, or a polymer that can be crosslinked with another component to form a delivered product (e.g., a hydrogel). A component can include a mixture or solution of one or more components (e.g., polymers and solvents). A component can include such components regardless of their state of matter (e.g., solid, liquid, or gas). A component can include both active and inactive components. For example, in some embodiments, the components can include certain polymers that can form the delivered product as well as drugs or other active ingredients. As another example, in some embodiments, the components can include drugs, including but not limited to small molecule drugs and biologics. In other embodiments, the components can include certain constituents to impart desired properties to the delivered product, including constituents that facilitate the delivered product being echogenic, radiopaque, radiolucent, or the like.
[0074] The terms "biomaterial product," "delivered biomaterial product," or "delivered product" include any substance delivered by any of the systems or delivery devices described herein. For example, the delivered product can be a biomaterial formed from multiple biomaterial components, delivered by any of the delivery systems described herein, and then delivered to a target location. Thus, the delivered product can be an implant or structure formed by the system and delivered by multiple biomaterial components that react together or assemble into a higher-order structure through covalent and / or non-covalent bonds. In some situations, the biomaterial can be delivered to a target location fully formed by the system. Although the delivered product can be considered fully formed (i.e., chemical reactions between the biomaterial components are complete), it can still undergo some changes (e.g., in vivo changes) after delivery. For example, the delivered biomaterial product can continue to absorb water and / or swell and / or expel impurities. In some embodiments, the delivered biomaterial product can be a hydrogel formed by crosslinking of two or more biomaterial components. The term "hydrogel" may refer to any water-swellable (majority of the mass of material, i.e., greater than 50%, water) crosslinked polymer network produced by the reaction of one or more components (e.g., polymers, monomers) and / or polymeric material that exhibits the ability to swell and retain a significant proportion of water within its structure, but is not soluble in water.
[0075] As used herein, the term "set" may refer to a plurality of features with multiple parts or a single feature. For example, when referring to a set of walls, the set of walls can be considered as one wall with multiple parts, or the set of walls can be considered as multiple separate walls. Thus, an integrally constructed article can include a set of walls. Such a set of walls can include multiple parts, for example, that are either contiguous or discontinuous with each other. A set of walls can also be made of multiple articles that are produced separately and then joined together (e.g., by welding, gluing, or any suitable method).
[0076] Figures 1 and 2 are schematic diagrams of a portion of a system 1000 (also referred to as a delivery system), according to an embodiment. As described herein, the system 1000 is configured to carry and combine multiple biomaterial components to form a biomaterial product that is delivered to a target location. Figures 3 and 4 are plots showing velocity profiles of a sample of the biomaterial components during use of the system 1000, and Figures 5-7 show the system 1000 being used to deliver a biomaterial product 3 (also referred to as a product) to a target location (specifically, within a body lumen L). The system 1000 includes a delivery device 1100, a container assembly 1300, a connector 1400, and a delivery member 1500 (see Figures 5 and 6).
[0077] The delivery device 1100 includes a cover 1110 and a drive assembly 1150. The cover 1110 is configured to receive at least a portion of the container assembly 1300. The cover 1110 can also include a drive assembly 1150. The cover 1110 can be made of any suitable material or materials and can provide any structural components suitable for receiving and / or holding a portion of the container assembly 1300 and performing any of the functions described herein. For example, in some embodiments, the cover 1110 can be constructed of multiple components that are coupled (e.g., by hinge joints, mechanical fasteners, or the like) to enclose and / or secure the container assembly 1300. In some embodiments, for example, the cover 1100 (or any of the covers described herein) can include a movable lid or cover to which the container assembly 1300 can be removably coupled and that can reveal a container portion. In use, the lid or cover can be closed to secure the container assembly 1300 within the cover 1110. In some embodiments, the cover 1100 (or any of the covers described herein) may include a locking member (or set of locking members) that can retain the container assembly 1300 within the cover and prevent premature and / or undesirable removal of the container assembly 1300.
[0078] The drive assembly 1150 can be any suitable assembly or mechanism for generating a driving force to drive the first biomaterial component 1 (also referred to as the first component), or the second biomaterial component 2 (also referred to as the second component), or both the first component 1 and the second component 2, from the container assembly 1300, as described herein. More specifically, the drive assembly 1150 can generate a driving force and / or drive the components within a desired range of speeds, forces, and / or flow rates. By controlling the delivery characteristics of the first component 1, the second component 2, and / or the delivery product 3, the drive assembly 1150 can repeatedly deliver precise amounts of the delivery product 3 to a target location, which in turn can provide more consistent and improved outcomes. Controlling the delivery characteristics can also ensure that any desired reactions (e.g., cross-linking reactions) between the first component 1 and the second component 2 can be completed within the system 1000. In other words, controlling the delivery characteristics can ensure that the delivery product 3 is formed entirely within the system (e.g., delivery member 1500), thereby ensuring that the first component 1 and the second component 2 are not delivered while the product 3 is not yet formed (or is only partially formed). Controlling the delivery characteristics can also limit potential damage to the target tissue. Such damage can be caused by delivery of an inappropriate amount of product, or delivery of the product too early or with a force that causes tissue damage. Finally, controlling the delivery characteristics can also limit clogging or blockages within the system 1000 (e.g., delivery member 1500).
[0079] As shown, the drive assembly 1150 includes a drive member 1160 that operably couples to the container assembly 1300 such that, upon actuation, the drive assembly 1150 can convey the first component 1 and the second component 2 from the container assembly 1300. The drive assembly 1150 can include any suitable mechanism for generating a driving force. For example, in some embodiments, the drive assembly can include an electromechanical drive (not shown in FIGS. 1 and 2) to generate the driving force. Such an electromechanical drive can include, for example, a motor-driven linear actuator, a hydraulic actuator (including, for example, a pump driven by electronic components), a magnetic-based actuator, a pneumatic actuator including an electromechanical valve that controls the pressure applied to the drive member 1160, or any other suitable electromechanical drive of the type described herein. In some embodiments, drive assembly 1150 and / or delivery device 1100 can include an electronic control system (not shown) that controls the electromechanical drive, as well as any other aspects of the drive assembly, to control the delivery characteristics of first component 1, second component 2, and / or delivery product 3, as described herein. For example, in some embodiments, the electronic control system can be similar to electronic control system 2200 described herein.
[0080] The container assembly 1300 includes a first container 1301 and a second container 1302, and can be coupled to and / or received within the cover 1110. The first container 1301 has a first end portion 1311, a second end portion 1312, and includes an elastomeric member (or stopper) 1315 therein. The first container 1301 defines a volume bounded on one side by the elastomeric member 1315 and containing a first component 1. The first container 1301 includes a first plunger 1320 having an end portion movably disposed within the first container 1301, such that movement of the first plunger 1320 causes movement of the elastomeric member 1315 to convey the first component 1 out of the first container 1301. An opposing end of the first plunger 1320 operably couples to (e.g., is configured to engage) the drive member 1160. The second container 1302 has a first end portion 1331, a second end portion 1332, and includes an elastomeric member (or stopper) 1335 therein. The second container 1302 defines a volume bounded on one side by the elastomeric member 1335 and containing the second component 2. The second container 1302 includes a second plunger 1340 having an end portion movably disposed within the second container 1302, such that movement of the second plunger 1340 causes movement of the elastomeric member 1335 to convey the second component 2 out of the second container 1302. An opposing end of the second plunger 1340 operably couples to (e.g., is configured to engage) the drive member 1160. In some embodiments, the elastomeric member is made of a butyl rubber, such as chlorobutyl or bromobutyl. In some embodiments, the elastomeric member may be covered with a film or other coating, such as ethylene tetrafluoroethylene (ETFE) or fluorinated ethylene propylene (FEP).
[0081] The first container 1301 and the second container 1302 (and any of the containers described herein) can be any suitable container. For example, the first container 1301 and / or the second container 1302 can be a cartridge, an ampoule, or a syringe. Additionally, the first container 1301 and the second container 1302 (and any of the containers described herein) can be any suitable size and can be constructed from any suitable material, such as type I borosilicate glass. For example, in some embodiments, the first container 1301 and the second container 1302 can have different sizes (e.g., different diameters). In this way, the container assembly can accommodate delivery of different volumes of the first component 1 and the second component 2 while maintaining a constant stroke length. In other embodiments, the first container 1301 and the second container 1302 can be the same size.
[0082] First component 1 and second component 2 can be any of the biomaterial components described herein. For example, in some embodiments, first component 1 and second component 2 can each be a water-soluble component (e.g., a monomer, macromer, polymer, or the like) that can be crosslinked (e.g., with the other component) to form a hydrogel (as the delivered biomaterial product). In some embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 5 minutes. In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 2 minutes. In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 1 minute. In yet other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 30 seconds. In some embodiments, the first component 1 is at least one of polyvinyl alcohol, alginic acid or modified alginic acid, chitosan or modified chitosan, polyethyleneimine, carboxymethylcellulose, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). The second component 2 is at least one of water or buffer, water or buffer with divalent cations such as calcium, a solution of reduced hyaluronic acid, a solution of polystyrene sulfonic acid, a solution of gelatin, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). In some embodiments, the polyvinyl alcohol, alginic acid, chitosan, polyethyleneimine, carboxymethylcellulose, polyethylene glycol terminated with a functional group, divalent cation, reduced hyaluronic acid, polystyrene sulfonic acid, or gelatin has a weight percentage ranging from about 1 to 30% in the solvent. In some embodiments, the polysaccharide may be modified with different functional groups. In some embodiments, polysaccharides and proteins may range in molecular weight from 10,000 to 1,000,000 grams / mole.In some embodiments, the polyvinyl alcohol, polystyrene sulfonate, polyethyleneimine, and polyethylene glycol may be linear, Y-shaped, 3-, 4-, 6-, or 8-armed, with molecular weights ranging from 1,000 to 1,000,000 grams / mole. The hydrogel may be any of the hydrogels described herein and may have any of the properties set forth herein. For example, in some embodiments, the hydrogel formed may be at least 90 percent water.
[0083] The first container 1301 and the second container 1302 are configured to couple to the connector 1400. By having the containers as separate items from the connector, the first container 1301 and the second container 1302 can be commercially available containers (e.g., syringes) in which the first component 1 and the second component 2, respectively, can be prepared for use. Moreover, this arrangement allows the first component 1 to be prepared (e.g., by mixing, diluting, etc.) in the first container 1301 separately from when the second component 2 is prepared in the second container 1302. However, in other embodiments, the container assembly 1300 can include a first container as well as a second container that are constructed integrally and / or integrally with the connector. In still other embodiments, the container assembly 1300 can include a single container that encompasses both the first component 1 and the second component 2.
[0084] As shown, the connector 1400 includes a first (or input) end portion 1401 and a second (or output) end portion 1402. The first end portion 1401 is configured to receive the tip (or connector) 1313 of the first container 1301 and the tip (or connector) 1333 of the second container 1302. The second end portion 1402 is configured to couple to a delivery member 1500 (see, for example, FIGS. 5 and 6). In this manner, a first component 1 can be transferred from the first container 1301 into the first end portion 1401 of the connector 1400 and out the second end portion 1402 of the connector to the delivery member 1500. Similarly, a second component 2 can be transferred from the second container 1302 to the first end portion 1401 of the connector 1400 and out the second end portion 1402 of the connector 1400 to the delivery member 1500. In some embodiments, the connector 1400 may be a mixing connector that internally mixes the first component 1 with the second component 2 before conveying the two components into the delivery member 1500. However, in other embodiments, the connector 1400 may keep the first component 1 separate from the second component 2, conveying the two components into the delivery member 1500 and mixing therein. By maintaining separate flow paths within the connector 1400, the first component 1 and the second component 2 may react (e.g., cross-link) outside of the connector 1400 (i.e., within the delivery member 1500), thereby limiting the possibility of clogging the connector 1400. In this manner, the connector 1400 may be used for multiple injections.
[0085] Delivery member 1500 can be any suitable delivery member, such as a needle, catheter, or any other device capable of delivering first component 1, second component 2, and / or biomaterial product 3 to a target location. In some embodiments, connector 1400 and delivery member 1500 can be integrally constructed or otherwise pre-assembled prior to use. In other embodiments, connector 1400 can be separate from delivery member 1500 and coupled to delivery member 1500 as part of a delivery procedure.
[0086] In use, after the container assembly 1300 is prepared and coupled to the delivery device 1100, the drive assembly 1150 can be actuated to generate a driving force. In this manner, the drive assembly 1150 (and drive member 1160) can simultaneously move the first plunger 1320 and the second plunger 1340 in time to dispense a portion of the first component 1 from the first container 1301 and a portion of the second component 2 from the second container 1302. The first component 1 and the second component 2 are conveyed through the connector 1400, as shown by arrows AA in FIG. 2. As described above, the first component 1 and the second component 2 can react (e.g., within the delivery member 1500, not shown in FIG. 2) to form the biomaterial product 3. The drive assembly 1150 is configured to move the first plunger 1320 and the second plunger 1340 such that the first component 1 and the second component 2 flow out of the connector 1400 at an flow rate within a predetermined rate range over time.
[0087] In some embodiments, the predetermined speed range is bounded by an upper speed threshold and a lower speed threshold. For example, FIG. 3 shows a plot of the exit speed as a function of time. As shown, during the injection time Δt, the speed of the components exiting the connector 1400 (and / or exiting the delivery member 1500) is bounded by an upper speed threshold Vupper and a lower speed threshold Vlower. By maintaining the speed below the upper speed threshold, the biomaterial can be delivered to limit the possibility of tissue damage (e.g., from an excessive speed causing potential tissue damage). Moreover, by maintaining the speed below the upper speed threshold, the delivered biomaterial product 3 can be ensured to be properly formed within the system 1000 (e.g., the delivery member 1500) before exiting the delivery member 1500. For example, if the gelation time of the biomaterial product 3 is approximately 15 seconds, the desired residence time of the first component 1 and the second component 2 within the delivery member is at least 15 seconds. Thus, the upper speed threshold can be predetermined based on the length of the delivery member 1500 and the gelation time of the biomaterial product 3. The predetermined speed range can be any suitable range that accommodates the desired delivery characteristics. For example, in some embodiments, the speed range can be between 0.1 mm / sec and 10 mm / sec. In other embodiments, the speed range can be between 0.1 mm / sec and 5 mm / sec. In other embodiments, the speed range can be between 0.01 mm / sec and 1 mm / sec.
[0088] Moreover, by maintaining the rate within a predetermined range for a predetermined delivery time, the system 1000 can deliver a volume of biomaterial product 3 that is within a desired volume range. In this manner, the amount of biomaterial can be precisely controlled. In some embodiments, the volume range is between about 5 microliters and about 1000 microliters. In other embodiments, the volume range is between about 50 microliters and 500 microliters. In yet other embodiments, the volume range is between about 50 microliters and 250 microliters. In yet other embodiments, the volume range is between about 75 microliters and 150 microliters.
[0089] Additionally, in some embodiments, the lower velocity threshold is above zero. By maintaining the exit velocity (and / or velocity within the delivery member 1500) above zero, the likelihood of clogging within the delivery member is reduced.
[0090] Although FIG. 3 depicts a quasi-constant velocity during the delivery time, in other embodiments, the drive assembly 1150 is configured to generate any desired velocity profile during the delivery time. Similarly, in some embodiments, the drive assembly 1150 is configured to generate any desired acceleration (rate of change of velocity) or jerk (rate of change of acceleration) profile during the delivery time. For example, FIG. 4 shows another plot of the outflow velocity as a function of time. As described above, during the injection time Δt, the velocity of the components outflowing from the connector 1400 (and / or outflowing from the delivery member 1500) is bounded by an upper velocity threshold Vupper and a lower velocity threshold Vlower. In addition, the drive assembly 1150 generates a velocity profile having an initial "high velocity" portion followed by a deceleration to a low velocity portion. In addition to providing control of the delivery velocity (and / or acceleration), in some embodiments, the drive assembly 1150 can be configured to maintain the driving force on the plunger applied by the drive member 1160 below a force threshold.
[0091] System 1000 (and any of the systems described herein) can be used to deliver a biomaterial product (such as any of the hydrogels described herein) to a target location. For example, FIGS. 5-7 are schematic diagrams illustrating system 1000 being used to deliver a biomaterial product 3 to a body lumen L. In use, container assembly 1300 can be prepared for use by preparing (e.g., mixing, reconstituting, etc.) first component 1 and second component 2 and loading first component 1 into first container 1301 and second component 2 into second container 1302. Container assembly 1300 can then be coupled to (or loaded into) delivery device 1100 and primed for use according to any of the methods described herein. Delivery member 1500 is then inserted into body lumen L as shown in FIG. 5. In some embodiments, delivery member 1500 can be inserted before connecting to connector 1400. However, in other embodiments, the delivery member 1500 can be coupled to the connector 1400 and then inserted into the body lumen L. As shown in FIG. 6, the delivery device 1100 can be actuated to initiate delivery of the first component 1 and the second component 2 through the connector 1400 and the delivery member 1500 as described above. Specifically, the delivery device 1100 can transport the first component 1 and the second component 2 within a desired velocity range over the delivery time. In this manner, a desired volume or length of the biomaterial product 3 can be delivered into the body lumen L. The delivery member 1500 can then be removed from the body lumen L as shown in FIG. 7. The body lumen L can be any suitable body lumen, such as, for example, an artery, a vein, a capillary, a blood vessel, a tissue, an intraorgan space, a lymphatic vessel, a duct of sperm, an epididymis, a fallopian tube, a duct, a bile duct, a hepatic duct, a gall bladder duct, a cystic duct, a pancreatic duct, a parotid duct, an organ, a uterus, a prostate, and the like. The target location can also be an organ of the gastrointestinal tract, or the circulatory system, or the respiratory system, or the nervous system, a subcutaneous space, an intramuscular space, or an interstitial space.
[0092] In some embodiments, the delivery device can include one or more feedback sensors to facilitate closed-loop control of the delivery characteristics of the biomaterial product. Such delivery characteristics can include the rate of components delivered from the container assembly, the rate of biomaterial product delivered, the maximum stress applied during delivery, the amount of biomaterial product delivered, a dip or a surge in force observed on the plunger, or the like. For example, FIGS. 8 and 9 are schematic diagrams of a system 2000 (also referred to as a delivery system), according to an embodiment. As described herein, the system 2000 is configured to carry and combine multiple biomaterial components to form a biomaterial product that is delivered to a target location. FIG. 10 is a plot showing a force profile of a sample of biomaterial components during use of the system 2000. The system 2000 includes a delivery device 2100, a container assembly 2300, a connector 2400, and a delivery member 2500.
[0093] The delivery device 2100 includes a housing 2110, a drive assembly 2150, and an electronic control system 2200. The housing 2110 includes a container receiving portion 2112 configured to receive at least a portion of a container assembly 2300. The container receiving portion 2112 can be an opening or a recess into which an end portion 2312 of the container assembly 2300 can be held during use. The container receiving portion 2112 can include any suitable retention structure, locking member, pin system, magnet, or the like. The housing 2110 can also include a drive assembly 2150 and an electronic control system 2200. As shown, the housing 2110 includes a handle 2120 that a user can grasp and / or manipulate during operation of the device 2100. The housing 2110 can be made from any suitable material or materials and can provide any structural components suitable for receiving and / or holding a portion of the container assembly 2300 and performing any of the functions described herein. For example, in some embodiments, the cover 2110 can be constructed from multiple pieces that are joined (e.g., by hinge joints, mechanical fasteners, or the like) to enclose and / or secure the container assembly 2300.
[0094] The container assembly 2300 has a first end portion 2311, a second end portion 2312 and includes an elastomeric member (or stopper) 2315 therein. The container assembly 2300 defines a first chamber (or volume) and a second chamber (or volume) separated from the first chamber by a separation member 2303. The first chamber contains a first component 1 and the second chamber contains a second component 2 that is separated from the first component (i.e., by the separation member 2303). The separation member 2303 can be a flexible member, a seal, or any other structure that separates and / or maintains the first chamber in fluid isolation from the second chamber. In this manner, the first component 1 and the second component 2 can be stored within the container assembly 2300 without reacting together. The first and second chambers are bounded on one side by the elastomeric member 2315. Container assembly 2300 includes a plunger 2320 having an end portion movably disposed within container assembly 2300, such that movement of plunger 2320 causes first component 1 and second component 2 to be carried out of container assembly 2300 by movement of elastomeric member 2315. Opposite ends of first plunger 2320 operably couple to (e.g., are configured to engage) a drive member 2160 of drive assembly 2150.
[0095] First component 1 and second component 2 can be any of the biomaterial components described herein. For example, in some embodiments, first component 1 and second component 2 can each be a water-soluble component (e.g., a monomer, macromer, polymer, or the like) that can be crosslinked (e.g., with the other component) to form a hydrogel (as the delivered biomaterial product). In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 5 minutes. In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 2 minutes. In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 2 minutes. In yet other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 30 seconds. In some embodiments, the first component 1 is at least one of polyvinyl alcohol, alginic acid or modified alginic acid, chitosan or modified chitosan, polyethyleneimine, carboxymethylcellulose, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). The second component 2 is at least one of water or buffer, water or buffer with divalent cations such as calcium, a solution of reduced hyaluronic acid, a solution of polystyrene sulfonic acid, a solution of gelatin, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). In some embodiments, the polyvinyl alcohol, alginic acid, chitosan, polyethyleneimine, carboxymethylcellulose, polyethylene glycol terminated with a functional group, divalent cation, reduced hyaluronic acid, polystyrene sulfonic acid, or gelatin has a weight percentage ranging from about 1 to 30% in the solvent. In some embodiments, the polysaccharide may be modified with different functional groups. In some embodiments, polysaccharides and proteins may range in molecular weight from 10,000 to 1,000,000 grams / mole.In some embodiments, the polyvinyl alcohol, polystyrene sulfonate, polyethyleneimine, and polyethylene glycol may be linear, Y-shaped, 3-stranded, 4-stranded, 6-stranded, or 8-stranded, with molecular weights ranging from 1,000 to 1,000,000 grams / mole. The hydrogel may be any of the hydrogels described herein and may have any of the properties set forth herein. For example, in some embodiments, the formed hydrogel may be at least 90 percent water. In other embodiments, the formed hydrogel may be >50% water.
[0096] The container assembly 2300 is configured to couple to the connector 2400 and the delivery member 2500. By having the container as a separate item from the connector and the delivery member, the first component 1 and the second component can each be prepared (e.g., by mixing, dilution, etc.) within the container assembly 2300 apart from when the connector 2400 is attached. However, in other embodiments, the container assembly 2300 can be provided as a pre-filled assembly. In other embodiments, the container assembly 2300 can be integral to and / or constructed integrally with the connector 2400. In still other embodiments, the container assembly 2300 can include two separate containers, such as the first container 1301 and the second container 1302 described herein.
[0097] The connector 2400 can be similar to any of the connectors described herein and includes a first (or input) end portion 2401 and a second (or output) end portion 2402. The first end portion 2401 is configured to receive a tip (or connector) 2313 of the container assembly 2300. The second end portion 2402 is configured to couple to a delivery member 2500. In this manner, a first component 1 and a second component 2 can be conveyed from the container assembly 2300 into the first end portion 2401 of the connector 2400 and out the second end portion 2402 of the connector to the delivery member 2500. In some embodiments, the connector 2400 can be a mixing connector that internally mixes the first component 1 with the second component 2 before conveying the two components into the delivery member 2500. However, in other embodiments, the connector 2400 can keep the first component 1 separate from the second component 2, and transport the two components into and mix within the delivery member 2500. By maintaining separate flow paths within the connector 2400, the first component 1 and the second component 2 can react (e.g., cross-link) outside of the connector 2400 (i.e., within the delivery member 2500), thereby limiting the possibility of clogging the connector 2400. In this manner, the connector 2400 can be used for multiple injections.
[0098] The delivery member 2500 can be any suitable delivery member, such as a needle, catheter, or any other device capable of delivering the first component 1, the second component 2, and / or the delivered biomaterial product to a target location. In some embodiments, the connector 2400 and the delivery member 2500 can be integrally constructed or otherwise pre-assembled prior to use. In other embodiments, the connector 2400 can be separate from the delivery member 2500 and coupled to the delivery member 2500 as part of the delivery procedure.
[0099] The drive assembly 2150 can be any suitable assembly or mechanism for generating a driving force to convey the first biomaterial component 1, or the second biomaterial component 2, or both the first component 1 and the second component 2, from the container assembly 2300, as described herein. More specifically, the drive assembly 2150 can generate a driving force and / or convey the components within a desired range of speeds, forces, and / or flow rates. As shown, the drive assembly 2150 includes a drive member 2160 that operably couples to the container assembly 2300 such that, upon actuation, the drive assembly 2150 can convey the first component 1 and the second component 2 from the container assembly 2300. The drive assembly 2150 can include any suitable mechanism for generating a driving force. For example, in some embodiments, the drive assembly can include an electromechanical drive (not shown in FIGS. 8 and 9) to generate a driving force. Such electromechanical drives may include, for example, a motor-driven linear actuator, a hydraulic actuator (including, for example, a pump driven by electronic components), a magnetic-based actuator, a pneumatic actuator including an electromechanical valve that controls the pressure applied to the drive member 2160, or any other suitable electromechanical drive of the type described herein. In some embodiments, the drive assembly 2150 (or any of the drive assemblies described herein) may include one or more springs configured to apply a force on the drive member. Additionally, these pre-filled drive assemblies may facilitate multiple injections with the same device.
[0100] The electronic control system 2200 controls the electromechanical drive and any other suitable aspects of the drive assembly that control the delivery characteristics of the first component 1, the second component 2, and / or the delivery product, as described herein. As shown, the electronic control system 2200 includes various modules, such as one or more sensors 2210, one or more processors 2201, one or more memory elements 2202, and a drive module 2204 and a user interface module 2206. Although FIGS. 8 and 9 show the electronic control system 2200 within the enclosure 2110, the electronic control system 2200 or portions thereof can be provided outside the enclosure 2110 (e.g., certain operations of the electronic control system 2200 can be performed within a cloud computing environment). As described herein, the electronic control system 2200 can automatically control the duration of delivery, the rate of the components, the maximum stress applied during delivery, and any other aspects of the delivery of the biomaterial product.
[0101] In particular, the electronic control system 2200 can control the drive assembly 2150 based on feedback from the sensor(s) 2210. The sensor 2210 can be separate and / or included within the electronic control system 2200 and can include any suitable sensor that generates a feedback signal associated with at least one of the position of the drive member 2160, the velocity of the drive member 2160, the acceleration of the drive member 2160, or the drive force applied by the drive member 2160. Such sensors can include, for example, imaging devices, optical sensors, accelerometers, temperature sensors, contact sensors, proximity sensors, position sensors, and / or any other suitable input devices. For example, in some embodiments, the sensor 2210 can be a linear position sensor (e.g., an LVDT or the like) that generates a feedback signal associated with the position of the drive member 2160. The feedback signal can also be used to determine a change in position (i.e., the velocity of the drive member 2160) during a delivery event. In other embodiments, the sensor 2210 can be a force sensor (e.g., a strain gauge force sensor) that generates a feedback signal associated with the force applied by or on the drive member 2160. In yet other embodiments, the sensor 2210 can be a current sensor that measures the current and / or voltage supplied to the electromechanical drive. From the measured current and / or voltage, the electronic control system 2200 (e.g., the drive module 2202) can calculate the power and therefrom the approximate force applied by the drive member 2160. The sensor 2210 can also be other types of sensors, such as an accelerometer (measuring vibration, motion, and / or acceleration of the drive member 2160), an optical sensor(s) that detects a particular position of the drive member 2160 and / or the container assembly 2300, or one or more switches. Although described as including one feedback sensor, the electronic control system 2200 (and any of the electronic control systems described herein) can include any number of sensors.For example, in some embodiments, the electronic control system 2200 may include a linear position sensor to measure the position of the drive member 2160 and an optical sensor to determine if the connector 2400 is coupled to the container assembly 2300. In some embodiments, the electronic control system 2200 is configured to detect and verify that the container assembly 2300 and / or the connector assembly 2400 are properly seated and coupled to the enclosure 2110. In some embodiments, the electronic control system 2200 is configured to monitor the position of the plunger 2320 relative to the drive member 2160 and / or the enclosure 2110 to improve accuracy and control of the plunger 2320 during priming or injection operations.
[0102] The processor 2201, and any of the processors described herein, may be any suitable processor for performing the methods described herein. In some embodiments, the processor 2201 may be configured to run and / or execute application modules, processes, and / or functions associated with the delivery device 2100. For example, the processor 2201 may be configured to run and / or execute the drive module 2204, the user interface module 2206 (which functions the input / output module), and / or any of the other modules described herein and perform the methods associated therewith. The processor 2201 may be, for example, a field programmable gate array (FPGA), an application specific integrated circuit (ASIC), a digital signal processor (DSP), and / or the like. The processor 2201 may be configured to read data from and / or write data to a memory, such as, for example, the memory 2202.
[0103] The memory 2202 (or any of the memory devices described herein) may be, for example, a random access memory (RAM), a memory buffer, a hard drive, a database, an erasable programmable read-only memory (EPROM), an electrically erasable programmable read-only memory (EEPROM), a read-only memory (ROM), a flash memory, a hard disk, a floppy disk, cloud storage, and / or the like. In some embodiments, the memory 2202 stores instructions that cause the processor 2201 to execute modules, processes, and / or functions associated with the delivery device 2100. For example, the memory 2202 can store instructions that cause the processor 2201 to execute any of the application modules described herein and perform the methods associated therewith.
[0104] The user interface module 2206 may be a hardware and / or software module (stored in the memory 2202 and / or executed by the processor 2201). The user interface module 2206 may be configured to receive input from a user and / or generate output to a user. For example, a user may press an actuator button 2230, which is operatively coupled to the electronic control system 2200. The user interface module 2206 may receive the input and generate one or more signals based on the user input. For example, in some embodiments, the user interface module 2206 may generate a signal to the drive assembly 2150 to "prime" the system by moving the drive member 2160 a predetermined distance. In other embodiments, the user interface module 2206 may generate a signal to the drive assembly 2150 to stop movement of the drive member 2160 (e.g., an error condition or a "stop" condition). The user interface module 2206 may also generate a signal to cause the electronic control system 2200 to generate one or more outputs. For example, in some embodiments, the electronic control system 2200 (and any of the electronic control systems described herein) includes an output device, such as an optical output device (e.g., an LED), an audible output device (e.g., a speaker), or a tactile output device (e.g., a vibration device). In such embodiments, the user interface module 2206 can generate a signal to cause the output device to generate an output (e.g., a visual, audible, or tactile output) to indicate a change in status associated with the delivery device 2100 (e.g., priming complete, mixing complete, injection complete) or an error condition. In some embodiments, the user interface module 2206 includes a graphical user interface that displays information about the system 2000 and receives input from the user.
[0105] The drive module 2204 may be a hardware and / or software module (stored in the memory 2202 and / or executed on the processor 2201). The drive module 2204 may be configured to receive a feedback sensor (e.g., from the sensor(s) 2210) and generate a drive signal based on the feedback signal to maintain the drive force below a threshold drive force. For example, after the container assembly 2300 is prepared and coupled to the delivery device 2100, the drive assembly 2150 may be actuated (e.g., by the actuator button 2230) to generate a drive force. In this manner, the drive assembly 2150 (and the drive member 2160) may move the plunger 2320 in time to dispense a portion of the first component 1 and a portion of the second component 2 from the container assembly 2300. The first component 1 and the second component 2 are conveyed through the connector 2400 into the delivery member 2500. The first component 1 and the second component 2 can react (e.g., within the delivery member 2500) to form a biomaterial product, as indicated by arrow BB. The drive module 2204 is configured to generate a drive signal to maintain the drive force below a drive force threshold during the delivery time. The drive signal can be, for example, a control signal that adjusts the level of power (e.g., current or power) applied to the drive assembly 2150 to maintain the drive force below the drive force threshold. In some embodiments, the drive assembly 2150 can include an electromechanical drive, such as a stepper motor. The drive signal can be a series of pulses that maintain and / or control the speed of the motor, thereby maintaining the force below the drive force threshold.
[0106] In some embodiments, the drive module 2204 can be configured to maintain the drive force below two or more thresholds. For example, FIG. 10 shows a plot of the drive force as a function of time. In some embodiments, the injection can be divided into two periods, a first period Δt1 and a second period Δt2. During the first period, which can be referred to as a "let-off" period, the drive module 2204 can be configured to maintain the drive force below the let-off force threshold (identified as F2 in FIG. 10). During the second period, which can be referred to as a "delivery" period, the drive module 2204 can be configured to maintain the drive force below the let-off force threshold (identified as F1 in FIG. 10). As shown, the drive force threshold is lower than the let-off force threshold. By controlling the drive assembly 2150 to generate a stronger force during the "start" period (i.e., the period that initiates the movement of the plunger 2320), the system can overcome stiction while still minimizing the impact of the strong force to limit potential tissue damage. 10 illustrates a drive force threshold that is less than the breakaway force threshold, in other embodiments, the drive force threshold can be equal to or greater than the breakaway force threshold. In still other embodiments, the drive force can be maintained below three or more different thresholds. For example, in some embodiments, the drive module 2204 can be configured to maintain the drive force below a drive threshold force curve that changes as a function of time. In some embodiments, the drive threshold curve can remain constant, increase, and / or decrease as a function of time.
[0107] In some embodiments, the drive module 2204 and / or the user interface module 2206 are configured to generate an error signal when the drive force exceeds a threshold drive force. In some embodiments, the error signal can cause an output device (not shown) to generate one of a visual, an audible, or a tactile output. In other embodiments, the error signal can cause a reduction in power or drive signal to the drive assembly 2150. Similarly, it could be said that the error signal can cause the drive assembly 2150 to reduce and / or stop motion to limit potential tissue damage caused by excessive force. In yet other embodiments, the drive module 2204 can generate a completion signal at the end of a delivery event to cause the drive assembly 2150 to stop motion.
[0108] By maintaining the driving force below a threshold driving force, the biomaterial can be delivered to limit the possibility of tissue damage (e.g., excessive speed and / or force causing potential tissue damage). Specifically, the driving force (i.e., the force applied by the delivery member) is related to the force that delivers the biomaterial to the target location (i.e., the delivery force). For example, the driving force creates pressure in the container assembly that moves the elastomeric member, thereby causing the first component 1 and the second component 2 to flow through the system (including the connector 2400 and the delivery member 2500). Pressure from the delivery site as well as frictional forces within the system act against the driving force. Thus, the delivery force applied to and / or within the target tissue is associated with the driving force and also losses (e.g., frictional forces) by the system. The threshold driving force can be any suitable value. For example, in some embodiments, the driving force can be maintained between 0.1 N and about 45 N. In other embodiments, the driving force can be maintained below about 20 N. In yet other embodiments, the driving force may be maintained below about 12N and / or within a range between about 7N and 12N.
[0109] In some embodiments, the drive module 2204 can be configured to maintain the velocity of the components exiting the connector 2400 (and / or exiting the delivery member 2500) within a desired velocity range, similar to the ranges described above for the delivery device 1100. As described above, the driving force required to deliver the components from the container assembly 2300 and the biomaterial product exiting the delivery member 2500 is related to the target flow rate (and therefore velocity), the material properties (e.g., viscosity), and the characteristics of the delivery system 2000 (e.g., the length of the delivery member and the friction between the elastomeric member 2315 and the container assembly 2300). In some situations (i.e., laminar flow of components), the pressure of the first component 1 and the second component 2 within the container assembly 2300 (related to the driving force exerted by the drive assembly 2150) can be modeled by Hagen-Poiseuille's law, as shown below: (1) P = (8 * μ * L * Q) / (Π * R 4 )
[0110] where P is the pressure of the first component 1 and / or second component 2 within the container assembly 2300, μ is the viscosity of the first component 1 and / or second component 2, L is the length of the delivery member 2500, Q is the flow rate of the first component 1, second component 2, and / or biomaterial product through the delivery member 2500, and R is the radius of the lumen defined by the delivery member 2500. Because the pressure (and therefore the driving force) required to inject a high viscosity fluid through a small diameter delivery member is proportional to the inverse of the fourth power of the radius of the delivery member lumen, the pressure of the components within the container assembly 2300 must be high enough to achieve the desired flow rate while being controlled to avoid excessive flow rate (or velocity) and / or high delivery (or exit) forces that may damage the target tissue. In addition, some applications require control of the injection location, amount and volume of delivered biomaterial, such as implanting the biomaterial into a tissue space, causing the material to enter or damage other tissue spaces. For example, if the injection is too slow, based on the mechanical properties and pressure of the implantation site, this may cause insufficient migration of the implant to the implant or obstruction, or leakage from the entry site. For example, if the injection is too fast, based on the mechanical properties and pressure of the implantation site, this may cause excessive tissue damage, or blood vessel rupture, or foreign body response, from implant damage.
[0111] In some embodiments, the container assembly 2300 (and any of the container assemblies described herein), the first component 1, and the second component 2 can be configured and / or formulated to facilitate maintaining a desired force and / or velocity profile. For example, in some embodiments, the container assembly 2300 (and any of the container assemblies described herein) can include two containers that are equal in size and contain substantially the same volume of components. Moreover, in some embodiments, any of the devices and methods described herein can include delivering equal amounts of the first component 1 and the second component 2 to generate a biomaterial product. Furthermore, in some embodiments, the viscosities of the first component 1 and the second component 2 can be "matched." Specifically, in some embodiments, the first component is characterized by a first viscosity, the second component is characterized by a second viscosity, and the second viscosity is within 25 percent of the first viscosity.
[0112] FIG. 11 is a flow diagram illustrating a method 10 of delivering a biomaterial product, according to an embodiment. The method 10 can be performed using any of the systems, delivery devices, and components described herein, such as, for example, the delivery systems 1000, 2000, 3000, and 4000 described herein, and / or the delivery devices 1100, 2100, 3100, and 4100 described herein. The method includes, at 11, conveying a first component stored in a first chamber of the container assembly to a first inlet of a connector that couples to the container assembly. The method further includes, at 12, conveying a second component stored in a second chamber of the container assembly to a second inlet portion of the connector. In some embodiments, the container assembly includes two separate containers, with the first component in the first container and the second component in the second container. However, in other embodiments, the container assembly includes a single container (similar to the container assembly 2300 described above), with the first and second components in separate chambers of the container. In some embodiments, the first component and the second component can be delivered to the connector simultaneously.
[0113] The first and second components are then conveyed through the delivery member at 12, through the outlet portion of the connector, and into the mixing volume of the delivery member. The delivery member removably couples to the connector. The first component crosslinks with the second component to form a hydrogel within the delivery member, such that conveying the first and second components through the outlet portion causes the hydrogel to be conveyed out of the outflow opening of the delivery member. Similarly, it can be said that the first and second components are delivered to ensure that the hydrogel (also referred to as the delivery product) forms entirely within the system (e.g., delivery member 1500), thereby ensuring that the first and second components are not delivered while the delivery product is not yet formed (or only partially formed).
[0114] The first and second components can be any of the components or compositions described herein. For example, in some embodiments, the first and second components are formulated to form a hydrogel with a gelation time. The first and second components are delivered through the delivery member through the outlet portion into the mixing volume within a flow rate range based on the gelation time such that the hydrogel is completely formed within the delivery member before being delivered through the outlet opening.
[0115] In some embodiments, the hydrogel is delivered from the outflow opening of the delivery member into a body lumen to at least partially occlude the body lumen, which can be any suitable body lumen, such as an artery, a vein, a capillary, a blood vessel, a tissue, an organ space, a lymphatic vessel, a vas deferens, an epididymis, an fallopian tube, a duct, a bile duct, a hepatic duct, a gall bladder duct, a pancreatic duct, a parotid duct, an organ, a uterus, a prostate, a gastrointestinal tract, or an organ of the circulatory system, or the respiratory system, or the nervous system, a subcutaneous space, an intramuscular space, or an interstitial space.
[0116] In some embodiments, method 10 optionally includes detaching the connector from the delivery member. The method may further optionally include coupling a second delivery member to the connector and conveying a second quantity of the first component and the second component through an outlet portion of the connector, into a mixing volume of the second delivery member, through the second delivery member, and to a second target location within the body.
[0117] In some embodiments, any of the delivery devices described herein can be configured to prime and / or inject the biomaterial product. "Priming" is defined as any step of preparing the material prior to injection, such as, for example, mixing or blending solutions within the device, removing dead volume (e.g., from a connector), and / or setting / adjusting the injection volume. "Injection" is defined as delivering the biomaterial product into the body. In one aspect, the priming and injection steps are predefined and cannot be adjusted by the user (e.g., physician). In one aspect, both the priming and injection steps are user adjustable. In one aspect, the priming and injection steps can be a combination of adjustable and non-adjustable.
[0118] In some embodiments, any of the devices described herein may be capable of performing one or more injections, such as delivering two biomaterial products from the same device into the same patient. In some embodiments, any of the devices described herein may perform a single priming step and a single injection, a single priming step and multiple injections, multiple priming steps and a single injection, and multiple priming steps and multiple injections. The priming and injection steps may be performed in a predefined order or in any order. The priming steps may be of the same volume or different volumes. In the case of multiple injections, each may be of the same volume or different volumes.
[0119] In some embodiments, the priming and / or injection(s) may occur by user input, e.g., a user's hand or finger may apply a force on a lever, switch, plunger, piston, and / or rod. In some embodiments, the priming and / or injection(s) may occur by a device, or motor, or actuator that applies a force on a lever, switch, plunger, and / or rod, and often the user may initiate these steps by a switch, trigger, button, lever, rod, graphical user interface, and / or voice command. The priming and / or injection(s) may occur by a combination of user input and device, such as a user providing some of the force and some of the force coming from a device, or motor, or actuator that includes or may act on a lever, switch, plunger, piston, and / or rod. In other embodiments, other actuators (e.g., linear actuators) or pumps (e.g., peristaltic pumps) can be used for priming and / or injection. One or more reservoirs may also be included for storing the biomaterial components, individually or together, as desired to provide a biomaterial ready for injection.
[0120] For example, Figures 12-14 show various views of a system 3000 including a delivery device 3100 for both priming and injecting a biomaterial, according to an embodiment. The system 3000 includes a delivery device 3100, a container assembly 3300, a connector 3400, and a delivery member 3500. The delivery device 3100 includes a housing 3110, a drive assembly 3150, and an electronic control system 3200. The housing 3110 is configured to receive the container assembly 3300. Specifically, the housing 3110 can include an opening or recess within which the container assembly 3300 can be retained during use. The housing 3110 can include any suitable retention structure, locking member, or the like. The housing 3110 also encompasses the drive assembly 3150 and the electronic control system 3200. As shown, the housing 3110 includes a handle 3120 that a user can grasp and / or manipulate during operation of the device 3100. The cover 3110 can be made from any suitable material or materials and can provide any structural components suitable for receiving and / or retaining a portion of the container assembly 3300 and performing any of the functions described herein.
[0121] The container assembly 3300 includes a first container 3301 and a second container 3302. The first container 3301 has a first end portion, a second end portion, and includes an elastomeric member (or stopper) 3315 therein. The first container 3301 defines a volume bounded on one side by the elastomeric member 3315 and containing a first component 1. The first container 3301 includes a first plunger 3320 having an end portion movably disposed within the first container 3301, such that movement of the first plunger 3320 causes movement of the elastomeric member 3315 to convey the first component 1 out of the first container 3301. An opposing end of the first plunger 3320 is operably coupled to (e.g., configured to engage) the drive member 3160. The second container 3302 has a first end portion, a second end portion, and includes an elastomeric member (or stopper) 3335 therein. The second container 3302 defines a volume bounded on one side by the elastomeric member 3335 and containing the second component 2. The second container 3302 includes a second plunger 3340 having an end portion movably disposed within the second container 3302, such that movement of the second plunger 3340 causes movement of the elastomeric member 3335 to convey the second component 2 out of the second container 3302. An opposing end of the second plunger 3340 operably couples to (e.g., is configured to engage) the drive member 3160. In this manner, both the first plunger 3320 and the second plunger 3340 can be moved by a single drive assembly 3150. First container 3301 and second container 3302 (and any of the containers described herein) can be any suitable containers, as described herein.
[0122] First component 1 and second component 2 can be any of the biomaterial components described herein. For example, in some embodiments, first component 1 and second component 2 can each be a water-soluble component (e.g., a monomer, macromer, polymer, or the like) that can be crosslinked (e.g., with the other component) to form a hydrogel (as the delivered biomaterial product). In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 5 minutes. In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 2 minutes. In other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 1 minute. In yet other embodiments, first component 1 and second component 2 are formulated such that the gelation time of the resulting hydrogel is less than 30 seconds. In some embodiments, the first component 1 is at least one of polyvinyl alcohol, alginic acid or modified alginic acid, chitosan or modified chitosan, polyethyleneimine, carboxymethylcellulose, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). The second component 2 is at least one of water or buffer, water or buffer with divalent cations such as calcium, a solution of reduced hyaluronic acid, a solution of polystyrene sulfonic acid, a solution of gelatin, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). In some embodiments, the polyvinyl alcohol, alginic acid, chitosan, polyethyleneimine, carboxymethylcellulose, polyethylene glycol terminated with a functional group, divalent cation, reduced hyaluronic acid, polystyrene sulfonic acid, or gelatin has a weight percentage ranging from about 1 to 30% in the solvent. In some embodiments, the polysaccharide may be modified with different functional groups. In some embodiments, polysaccharides and proteins may range in molecular weight from 10,000 to 1,000,000 grams / mole.In some embodiments, the polyvinyl alcohol, polystyrene sulfonate, polyethyleneimine, and polyethylene glycol may be linear, Y-shaped, 3-, 4-, 6-, or 8-armed, with molecular weights ranging from 1,000 to 1,000,000 grams / mole. The hydrogel may be any of the hydrogels described herein and may have any of the properties set forth herein. For example, in some embodiments, the formed hydrogel may be at least 90 percent water.
[0123] The container assembly 3300 is configured to couple to the connector 3400, which in turn couples to the delivery member 3500. By having the container as an item separate from the connector 3400 and the delivery member 3500, the first component 1 and the second component can each be prepared (e.g., by mixing, dilution, etc.) within the container assembly 3300 separate from when the connector 3400 is attached. However, in other embodiments, the container assembly 3300 can be provided as a pre-filled assembly.
[0124] The connector 3400 can be similar to any of the connectors described herein and includes a first (or input) end portion and a second (or output) end portion 3402. The first end portion includes a first inlet 3404 that couples to a tip (or connector) of the first container 3301 and a second inlet 3406 that couples to a tip (or connector) of the second container 3302. The second end portion 3402 is configured to couple to a delivery member 3500 (FIGS. 12-14 show the connector 3400 coupling to a hub 3520 of the delivery member 3500). As shown in FIG. 14, the connector 3400 defines a first passageway (or lumen) 3411 that places the first inlet 3404 in fluid communication with the second end portion 3402, and a second passageway (or lumen) 3412 that places the second inlet 3406 in fluid communication with the second end portion 3402. In this manner, the first component 1 can be delivered from the first container 3301 into the first end portion of the connector 3400 and from the second end portion 3402 of the connector to the delivery member 3500. Similarly, the second component 2 can be delivered from the second container 3302 into the first end portion of the connector 3400 and from the second end portion 3402 of the connector 3400 to the delivery member 3500. As shown, the connector 3400 keeps the first component 1 separate from the second component 2 and delivers the two components into the hub 3520 of the delivery member 3500 where they mix. By maintaining separate flow paths within the connector 3400, the first component 1 and the second component 2 can react (e.g., cross-link) outside of the connector 3400 (i.e., within the delivery member 3500), thereby limiting the possibility of clogging with the connector 3400. In this manner, the connector 3400 can be used for multiple injections.
[0125] The drive assembly 3150 can be any suitable assembly or mechanism for generating a driving force to convey the first biomaterial component 1 and the second biomaterial component 2 from the container assembly 3300. As shown, the drive assembly 3150 includes a drive member 3160 having an end portion 3162 that operably couples to the container assembly 3300 (specifically, the first plunger 3320 and the second plunger 3340) such that, upon actuation, the drive assembly 3150 can convey the first component 1 and the second component 2 from the container assembly 3300. The drive assembly 3150 can include any suitable mechanism for generating a driving force. For example, in some embodiments, the drive assembly can include an electromechanical drive (not shown in FIGS. 12-14) to generate the driving force. Such electromechanical drives may include, for example, a motor-driven linear actuator, a hydraulic actuator (e.g., including a pump driven by electronic components), a magnetic-based actuator, a pneumatic actuator including an electromechanical valve that controls the pressure applied to the drive member 3160, or any other suitable electromechanical drive of the type described herein.
[0126] The electronic control system 3200 controls the electromechanical drive and any other suitable aspects of the drive assembly that control the delivery characteristics of the first component 1, the second component 2, and / or the delivery product, as described herein. Additionally, the electronic control system 3200 can cause the drive assembly 3150 to generate separate motions associated with priming and injecting operations. The electronic control system 3200 can be similar to (and can include any of the features of) the electronic control system 2200. For example, although not shown in FIGS. 12-14, the electronic control system 3200 can include one or more sensors, one or more processors, one or more memory elements, and various modules such as a drive module and a user interface module. As shown, the electronic control system 3200 includes an actuator (or trigger) 3230, a first user input switch 3232 (also referred to as a "priming switch"), and a second user input switch 3233 (also referred to as an "injection switch"). The electronic control system 3200 is powered by a power source 3240, which can be any suitable power source, such as a battery (including a rechargeable battery), an AC / DC converter (e.g., to facilitate AC powered devices), etc. The actuator 3230, the priming switch 3232, and the injection switch 3233 can each provide input to the electronic control system 3200 by a user interface module (not shown, but which can be similar to the user interface module 2206 described above).
[0127] In use, the electronic control system 3200 can control the drive assembly 3150 based on user input received via the priming switch 3232 and the injection switch 3233. Specifically, the electronic control system 3200 (and / or the drive module) is configured to generate a priming signal upon actuation of the priming switch 3232 to move the drive member 3160 a priming distance. The priming signal can be an electronic signal (e.g., a current, several pulses, or the like) that causes the electromechanical drive of the drive system 3150 to move the drive member 3160 a predetermined distance (i.e., the priming distance) sufficient to prime the system 3000 in preparation for (and before) an injection operation and during the injection operation. In some embodiments, the electronic control system 3200 (and / or the drive module) is configured to generate the priming signal in response to actuation of the priming switch 3232 and the actuator 3230. For example, in some embodiments, a user can first activate the priming switch 3232 to place the electronic control system 3200 in a priming mode. Then, after the user activates the actuator 3230, the electronic control system 3200 (and / or the drive module) generates a priming signal to initiate the priming operation (movement of the drive member 3160).
[0128] Additionally, the electronic control system 3200 (and / or the drive module) is configured to generate an injection signal upon activation of the injection switch 3233 to move the drive member 3160 an injection distance. The injection signal can be an electronic signal (e.g., a current, several pulses, or the like) that causes the electromechanical drive of the drive system 3150 to move the drive member 3160 a predetermined distance (i.e., the injection distance) sufficient to deliver a desired volume of biomaterial product (e.g., hydrogel). In some embodiments, the electronic control system 3200 (and / or the drive module) is configured to generate the injection signal in response to activation of the injection switch 3233 and the actuator 3230. For example, in some embodiments, a user can first activate the injection switch 3233 to place the electronic control system 3200 in an injection mode. Then, after the user activates the actuator 3230, the electronic control system 3200 (and / or the drive module) generates an injection signal to initiate the injection operation (movement of the drive member 3160).
[0129] In some embodiments, the electronic control system 3200 (and / or drive module) can generate, control, and / or adjust drive signals as described herein to control the electromechanical drive to maintain the flow force of the hydrogel delivered from the delivery member 3500 below a threshold flow force. In some embodiments, the electronic control system 3200 (and / or drive module) can generate, control, and / or adjust drive signals as described herein to control the electromechanical drive to maintain the rate of the first component 1, the second component 2, and / or the biomaterial product delivered within a desired rate range.
[0130] In some embodiments, the electronic control system 3200 (and any of the electronic control systems described herein) is configured to detect an error condition associated with the delivery system 3000 and / or the delivery device 3100 and generate a notification to a user. For example, in some embodiments, the electronic control system 3200 includes an output device (e.g., a light, a speaker, or a vibration device). The electronic control system 3200 may generate an error signal upon activation of the injection switch 3233 but the priming operation is not completed. In this manner, the electronic control system 3200 may eliminate or reduce the possibility of an improper injection being completed (due to failure to properly prime the device). In some embodiments, the electronic control system 3200 (and any of the electronic control systems described herein) includes a sensor configured to generate a feedback signal indicating whether the connector 3400 is coupled to the container assembly 3300. The electronic control system 3200 (and / or the drive module) may generate an error signal when the feedback signal indicates that the connector 3400 is not coupled to the container assembly 3300. In this manner, the electronic control system 3200 can eliminate or reduce the possibility of an improper injection being completed when the connector 3400 is not properly coupled to the container assembly 3300. Specifically, the error signal can cause an output device to generate one of a visual, an audible, or a tactile output. In some embodiments, the error signal can disable the injection signal or the drive signal or otherwise prevent movement of the drive member 3160.
[0131] In some embodiments, the system 3000 can be used to perform multiple injections using the same container assembly 3300. For example, in some embodiments, the system 3000 (and any of the systems described herein) can be used to deliver a biomaterial product (e.g., a hydrogel) to occlude each of a patient's two vas deferens. In such embodiments, the container assembly 3300 can include a first component 1 and a second component 2 in sufficient quantities to deliver two separate biomaterial products to the patient, one to each vas deferens. Such methods are described below with reference to methods 20 and 30. In such embodiments, the system 3000 can be primed twice (once before each injection event). Two priming events and two injection events are generally described in FIG. 15, which shows a schematic diagram of a first container 3301. As shown, the first container 3301 has a first end portion 3311 and a second end portion 3312. The second end portion 3312 includes a flange 3314 that serves as a reference point for identifying the distance to move an elastomeric member 3315 (not shown in FIG. 15) during each of the priming and injection operations.
[0132] As shown, the first container 3301 (and any of the containers described herein) can be filled with the first component prior to coupling into the delivery device 3100. The first container 3301 can be pre-filled with the first component, or an alternative that the user can mix, and / or prepare the first component on-site and then manually fill the first container 3301 prior to use. As shown, the amount of the first component in the first container 3301 varies between a maximum fill volume (identified as FILLmax) and a minimum fill volume (identified as FILLmin). In use, upon initiating a first priming event, the movable member 3160 moves from a start position (i.e., a home position of the drive member 3160 and / or drive assembly 3150) through a first priming distance to a first priming position (identified as P1). During the first priming event, the first component 1 and the second component 2 are transported from the first container 3301 and the second container 3302, respectively, through the first lumen 3411 and the second lumen 3412, respectively, of the connector 3400. Because the first component 1 is separated from the second component 2 within the connector 3400, no cross-linking of the components occurs during the first priming operation. The user can wipe any residue off the tip of the connector 3400. The system 3000 is then ready to couple to the delivery member 3500 to complete the first injection.
[0133] In use, initiating a first injection event causes the movable member 3160 to move from a first priming position P1 through a first injection distance to a first injection position (identified as INJ1). During the first injection event, additional amounts of the first component 1 and second component 2 are transported from the first container 3301 and second container 3302, respectively, through the connector 3400 into the mixing volume of the delivery member 3500 and through the delivery member 3500 to a target location.
[0134] Since the first component 1 is separated from the second component 2 within the connector 3400, cross-linking of the components does not occur during the first priming operation. The user can wipe any residue from the tip of the connector 3400. The system 3000 can then be connected to the delivery member 3500 at any time to complete the cross-linking of the two components and subsequently the first injection. As described herein, during the first injection event, the delivery characteristics (i.e., speed, flow rate, maximum delivery force) of the first component 1 and the second component 2 can be controlled to ensure that the delivered biomaterial product (e.g., hydrogel) is fully formed within the delivery member 3500 before being delivered to the target location and is delivered in a repeatable and precise manner that does not damage the target tissue. After the first injection event is completed, the connector 3400 can be disconnected from the delivery member 3500.
[0135] A second priming event can be initiated to move the movable member 3160 from the first injection position INJ1 through a second priming distance to a second priming position (identified as P2). The second priming event can be similar to the first priming event, as described above. However, because the second priming event begins at the first injection position INJ1 by the movable member 3160, the system 3000 does not need to address the variability of the initial fill volume of the first container 3301. Thus, the second priming distance can be shorter than the first priming distance. After the second priming event, the user can again wipe any residue from the tip of the connector 3400. The system 3000 can then be connected to the second delivery member 3500 (separate from the first delivery member) at any time to complete the second injection. During the second injection event, the movable member 3160 moves from the second priming position P2 through a second injection distance to a second injection position (identified as INJ2). During the second injection event, additional amounts of the first component 1 and the second component 2 are delivered from the first container 3301 and the second container 3302, respectively, through the connector 3400 into the mixing volume of the second delivery member 3500 and through the second delivery member 3500 to the target location. The second injection event is similar to the first injection event described above. Once the second injection event is completed, the container assembly 3300 and the delivery member 3500 can be removed from the device 3100 and discarded.
[0136] As described above, the drive member 3160 and / or drive assembly 3150 are associated with a start position (or home position) which is a position where the drive member 3160 first begins a sequence of motions and / or where the drive member 3160 returns to after completion of a sequence of motions. The home position may be maintained at a constant (or substantially constant) distance from the flange 3314 of the first container 3301 (and any of the containers described herein). By maintaining a constant home position relative to the container assembly 3300, the device 3100 may repeatedly deliver a desired amount of a component to the same or different patients, for multiple different motions, using multiple different container assemblies 3300.
[0137] In some embodiments, the container assembly may include a cartridge or other structure to ensure that the container therein couples to the delivery device in a desired position (i.e., relative to the home position of the drive assembly). By using a cartridge that includes marking and / or alignment features, the possibility of misalignment and / or improper positioning by the user may be minimized. For example, FIGS. 16-31 are various views of a system 4000 according to an embodiment that includes, among other things, a cartridge for positioning the container assembly. The system 4000 includes a delivery device 4100 (e.g., FIGS. 16 and 17), a container assembly 4300 (e.g., FIGS. 18 and 22), a connector 4400 (e.g., FIGS. 18-20), and a delivery member 4500 (e.g., FIGS. 27 and 28). The delivery device 4100 includes a shroud 4110, a drive assembly 4150, and an electronic control system 4200.
[0138] The cover 4110 includes a container receiving portion 4112 configured to receive at least a portion of the container assembly 4300. The container receiving portion 4112 is an open portion of the cover 4110 bounded by a bottom surface on which the container assembly 4300 and / or the cartridge 4350 can be placed. The container receiving portion 4112 includes a first retainer 4114 and a second retainer 4115. As described in more detail below, the first retainer 4114 engages a first engagement portion 4361 (see FIG. 21 ) of the cartridge 4350 to hold the cartridge 4350 in a fixed position within the cover 4110. The second retainer 4115 engages a second engagement portion 4363 (see FIG. 21 ) of the cartridge 4350 to hold the cartridge 4350 in a fixed position within the cover 4110. The fixed position can be fixed relative to a fixed position of the drive assembly 4150 and / or the drive member 4160. Additionally, as shown, the second retainer 4115 includes a locking protrusion that can cover the cartridge 4350 and releasably retain it within 4110. The second retainer 4115 is deformable such that it can deform to move the locking protrusion from the second engagement portion 4363 to allow removal of the cartridge 4350.
[0139] The enclosure 4110 also contains a drive assembly 4150 and an electronic control system 4200. As shown, the enclosure 4110 includes a handle 4120 that a user can grasp and / or manipulate during operation of the device 4100. The enclosure 4110 can be made from any suitable material or materials and can provide any structural components suitable for receiving and / or retaining a portion of the container assembly 4300 and performing any of the functions described herein.
[0140] The container assembly 4300 includes a first container 4301 and a second container 4302. The first container 4301 has a first end portion 4311, a second end portion 4312 and includes an elastomeric member (or stopper) 4315 therein. The second end portion 4312 includes a flange 4314 that can be coupled into a cartridge 4350, as described below. The first container 4301 defines a volume bounded on one side by the elastomeric member 4315 and containing a first component. The first container 4301 includes a first plunger 4320 having a first end portion 4321 and a second end portion 4322. The first end portion 4321 is movably disposed within the first container 4301 such that movement of the first plunger 4320 causes movement of the elastomeric member 4315 to convey the first component from the first container 4301. A second end portion 4322 of the first plunger 4320 terminates in a flange 4323 that operably couples to (e.g., is configured to engage with) the drive member 4160. The second container 4302 has a first end portion 4331, a second end portion 4332, and includes therein an elastomeric member (or stopper) 4335. The second end portion 4332 includes a flange 4334 that can be coupled within the cartridge 4350, as described below. The second container 4302 defines a volume bounded on one side by the elastomeric member 4335 and containing the second component. The second container 4302 includes a second plunger 4340 having a first end portion 4341 and a second end portion 4342. The first end portion 4341 is movably disposed within the second container 4302 such that movement of the second plunger 4340 causes movement of the elastomeric member 4335 to convey the second component from the second container 4302. The second end portion 4342 terminates in a flange 4343 that operably couples to (e.g., is configured to engage with) the drive member 4160.
[0141] 21 and 22, the cartridge 4350 defines a first recess or opening 4351 for receiving a portion of the first container 4301 (i.e., container body) and a second recess or opening 4352 for receiving a portion of the second container 4302 (i.e., container body). The cartridge 4350 includes a first retainer (or clip) 4353, a second retainer (or clip) 4354, a first engagement portion 4361, and a second engagement portion 4363. The first retainer 4353 forms a boundary of the first recess 4351 and engages the container body of the first container 4301 to hold the first container 4301 within the cartridge. The second retainer 4354 forms a boundary of the second recess 4352 and engages the container body of the second container 4302 to hold the second container 4302 within the cartridge. One or both of the first retainer 4353 and the second retainer 4354 may be deformable to form an interference fit with the respective container body. In this way, the container can be securely retained within the cartridge 4350. The first retainer 4353 and the second retainer 4354 can position the container in a fixed position in a first direction, i.e., perpendicular to the longitudinal centerline CL of the container assembly 3300 and / or the delivery device 3100. The cartridge 4350 defines flange grooves 4355 that receive the flanges 4314 (of the first container 3301) and the flanges 4334 (of the second container 3302). In this way, the position of the container can be fixed along the centerline CL.
[0142] The first engagement portion 4361 of the cartridge defines a notch 4362 that receives and / or matingly engages the first retainer 4114 of the cover 4110. The second engagement portion 4363 includes a surface with which a locking protrusion of the second retainer 4115 can engage to releasably retain the cartridge 4350 (and thus the container assembly 3300) within the cover 4110 (see, e.g., FIGS. 24 and 25 ). This arrangement allows the cartridge 4350 to couple to the delivery device 4100 in a fixed position relative to a fixed position associated with the drive assembly 4150. In other embodiments, the cover can define one or more recesses or notches and the cartridge can include one or more protrusions to securely (and releasably) couple the cartridge 4350 to the cover 4110.
[0143] The plunger link 4370 is configured to couple to the flange 4323 of the first plunger 4320 and the flange 4343 of the second plunger 4340. Specifically, the plunger link 4370 includes a surface that defines a retention groove 4371 and to which a driving force can be applied by the drive member 4160. The retention groove 4371 receives the flange 4323 and the flange 4343. The plunger link 4370 facilitates the use of a single drive assembly 4350 to generate a driving force to repeatedly move both the first plunger 4320 and the second plunger 4340. However, in other embodiments, a plunger link is not included. In some embodiments, the first plunger 4320 and the second plunger 4340 can include an engagement portion to couple or attach to a piston (or stopper) in each container.
[0144] The first and second components can be any of the biomaterial components described herein. For example, in some embodiments, the first and second components can each be a water-soluble component (e.g., a monomer, macromer, polymer, or the like) that can be crosslinked (e.g., with the other component) to form a hydrogel (as the delivered biomaterial product). In some embodiments, the first and second components are formulated such that the gelation time of the resulting hydrogel is less than 5 minutes. In other embodiments, the first and second components are formulated such that the gelation time of the resulting hydrogel is less than 2 minutes. In other embodiments, the first and second components are formulated such that the gelation time of the resulting hydrogel is less than 1 minute. In yet other embodiments, the first and second components are formulated such that the gelation time of the resulting hydrogel is less than 30 seconds. In some embodiments, the first component is at least one of polyvinyl alcohol, alginic acid or modified alginic acid, chitosan or modified chitosan, polyethyleneimine, carboxymethylcellulose, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). The second component is at least one of water or buffer, water or buffer with divalent cations such as calcium, a solution of reduced hyaluronic acid, a solution of polystyrene sulfonic acid, a solution of gelatin, and / or polyethylene glycol terminated with a bioorthogonal functional group (e.g., amine, thiol, maleimide, azide, activated ester). In some embodiments, the polyvinyl alcohol, alginic acid, chitosan, polyethyleneimine, carboxymethylcellulose, polyethylene glycol terminated with a functional group, divalent cation, reduced hyaluronic acid, polystyrene sulfonic acid, or gelatin has a weight percentage ranging from about 1 to 30% in the solvent. In some embodiments, the polysaccharide may be modified with different functional groups. In some embodiments, polysaccharides and proteins may range in molecular weight from 10,000 to 1,000,000 grams / mole.In some embodiments, the polyvinyl alcohol, polystyrene sulfonate, polyethyleneimine, and polyethylene glycol may be linear, Y-shaped, 3-, 4-, 6-, or 8-armed, with molecular weights ranging from 1,000 to 1,000,000 grams / mole. The hydrogel may be any of the hydrogels described herein and may have any of the properties set forth herein. For example, in some embodiments, the formed hydrogel may be at least 90 percent water.
[0145] The container assembly 4300 is configured to couple to the connector 4400, which in turn couples to the delivery member 4500. By having the container as an item separate from the connector 4400 and the delivery member 4500, the first and second components can each be prepared (e.g., by mixing, dilution, etc.) within the container assembly 4300 apart from when the connector 4400 is attached. However, in other embodiments, the container assembly 4300 can be provided as a pre-filled assembly and can include a pre-filled syringe or a pre-filled cartridge. In some embodiments, the pre-filled assembly can be provided with pre-mixed components or the pre-filled assembly can be provided with separate powder(s) and solvent(s) that can be combined prior to use with the delivery device 4100.
[0146] The connector 4400 can be similar to any of the connectors described herein and includes a first (or input) end portion 4401 and a second (or output) end portion 4402. The first end portion includes a first inlet 4404 that couples to a tip (or connector) of the first container 4301 (e.g., can be coupled to a luer connector (not shown) of the first container 4401 via a flange 4405). The first end portion includes a second inlet 4406 that couples to a tip (or connector) of the second container 4302 (e.g., can be coupled to a luer connector (not shown) of the second container 4402 via a flange 4407). The second end portion 4402 is configured to couple to a delivery member 4500 (see FIG. 27). The second end portion 4402 includes a fitting 4420 that can rotate relative to the connector 4400 and couple to a mating flange of a hub 4520 of the delivery member 4500. In some embodiments, the fitting 4420 and the connector 4400 can include one or more indicators to provide a visual cue to the user to confirm that a secure connection has been made. In some embodiments, the connector 4400 and the delivery member 4500 can include one or more indicators to provide a visual cue to the user to confirm that a secure connection has been made. In some embodiments, a sensor can be provided in (or associated with) the connector 4400 and / or the delivery member 4500 to detect a secure connection. For example, the sensor can communicate with the electronic control system 4200 to provide an audible or visual cue to the user that a secure connection has been made, or a warning if a secure connection has not been made. In some embodiments, the sensor can communicate with the electronic control system 4200 to inhibit the drive assembly 4150 from operating if an incomplete or improper connection has occurred.
[0147] Similar to the connector 3400 described above, the connector 4400 defines a first passageway having a first inlet 4404 in fluid communication with a first outlet 4415 (see FIG. 20 ) and a second passageway having a second inlet 4406 in fluid communication with a second outlet 4416. In this manner, a first component can be conveyed from a first container 4301 into a first end portion of the connector 4400 and through the first outlet 4415 into a mixing volume 4521 of the delivery member 4500. Similarly, a second component can be conveyed from a second container 4302 into a first end portion of the connector 4400 and through the second outlet 4416 into the mixing volume 4521 of the delivery member 4500. As such, the connector 4400 keeps the first component separate from the second component and conveys the two components into and mixes within the hub 4520 of the delivery member 4500. By maintaining separate flow paths within the connector 4400, the first and second components can react (e.g., cross-link) outside of the connector 4400 (i.e., within the delivery member 4500), thereby limiting the possibility of clogging the connector 4400. In this manner, the connector 4400 can be used for multiple injections.
[0148] The delivery member 4500 includes a catheter 4510 that couples to a hub 4520. The hub 4520 includes a flange or other suitable fastening mechanism that allows the hub 4520 to couple to a fitting 4420 of the connector 4400. As shown in FIG. 27 , the hub 4520 defines a mixing volume 4521 in which the first and second components can be carried and mixed together. The catheter 4510 includes a first end 4511 that couples to the hub 4520 and a second end 4512 that can be inserted into a body lumen or other target location.
[0149] The drive assembly 4150 can be any suitable assembly or mechanism for generating a driving force to convey the first and second biomaterial components from the container assembly 4300. As shown, the drive assembly 4150 includes an electromechanical drive 4152 and a drive member 4160. The electromechanical drive 4152 can be any of the electromechanical drives described herein, and in this embodiment is a linear actuator powered by a stepper motor that generates the driving force. The drive member 4160 has an end portion 4162 that operably couples to the container assembly 4300 by a contact surface 4163. Specifically, upon actuation, the contact surface 4163 can engage a corresponding surface of a plunger link 4370 such that the drive assembly 4150 can move the first plunger 4320 and the second plunger 4340 along the longitudinal centerline CL. In some embodiments, the drive assembly 4150 may include one or more springs and dampers in addition to or instead of the electromechanical drive 4152 to provide actuation control of the first plunger 4320 and the second plunger 4340 along the longitudinal centerline CL.
[0150] The electronic control system 4200 controls the electromechanical drive 4152 and other aspects of the drive assembly 4150 that control the delivery characteristics of the first component, the second component, and / or the delivery product, as described herein. Additionally, the electronic control system 4200 can cause the drive assembly 4150 to generate separate motions associated with priming and injecting operations, as described above with respect to the system 3000. The electronic control system 4200 can be similar to (and can include any of) the electronic control system 2200 and the electronic control system 3200. For example, although not shown, the electronic control system 4200 can include various modules, such as one or more sensors, one or more processors, one or more memory elements, and a drive module and a user interface module. As shown, the electronic control system 4200 includes a set of actuators (or triggers) 4230 and output devices 4221. Although not shown, electronic control system 4200 may include various user input switches, such as a priming switch and / or an injection switch, as described above with respect to system 3000. Electronic control system 4200 is powered by power source 4240, which may be any suitable power source, such as a battery (including a rechargeable battery), an AC / DC converter (e.g., to facilitate AC powered devices), etc. Actuator 4230 may provide input to electronic control system 4200 by way of a user interface module (not shown, but which may be similar to user interface module 2206 described above).
[0151] In use, the electronic control system 4200 can control the drive assembly 4150 based on the received user input to generate any of the priming signal, the infusion signal, and the drive signal, as described above. For example, the electronic control system 4200 (and / or the drive module) can generate, control, and / or adjust the drive signal as described herein to control the electromechanical drive to maintain the flow force of the biomaterial product (e.g., hydrogel) delivered from the delivery member 4500 below a flow force threshold. In some embodiments, the electronic control system 4200 (and / or the drive module) can generate, control, and / or adjust the drive signal as described herein to control the electromechanical drive to maintain the rate of the first component, the second component, and / or the biomaterial product delivered within a desired rate range.
[0152] FIG. 32 is a flow diagram illustrating a method 20 of delivering a biomaterial product, according to an embodiment. Although the method 20 is described in relation to the delivery system 4000, in other embodiments, the method 20 can be performed using any of the systems, delivery devices, and components described herein, such as, for example, the delivery systems 1000, 2000, and 3000 and / or delivery devices 1100, 2100, and 3100 described herein. In some embodiments, the cartridge assembly can be prepared prior to the delivery operation. For example, a first component can be prepared and loaded into a first container (or syringe), and a second component can be prepared and loaded into a second container (or syringe). With reference to FIG. 22, the container can then be placed into a cartridge (e.g., cartridge 4350). As shown in FIGS. 23 and 24, the container assembly 4300 (including the cartridge 4350) can be loaded into the container receiving portion 4112 of the cover 4100. Specifically, the cartridge 4350 can be aligned to receive the first retainer 4114 within the notch 4362. The cartridge 4350 can be rotated, as shown by arrow CC in FIG. 24, to secure the second retainer 4115 about the second engagement portion 4363.
[0153] After filling the container assemblies, the method includes connecting an inlet of a connector to the container assembly at 21. As shown and described above, a connector (e.g., connector 4400) can be connected to each of the containers by a luer fitting or the like. The system can then be primed as described above with respect to system 3000. Specifically, the method includes priming the connector at 22 by conveying a first portion of a first component from the container assembly to a first outlet (e.g., first outlet 4415) of the connector and a first portion of a second component from the container assembly to a second outlet (e.g., second outlet 4416) of the connector. Any remaining amounts of components can optionally be wiped off the end surface 4413 of the connector.
[0154] After priming, at 23, the delivery member couples to the connector to place the first outlet of the connector and the second outlet of the connector in fluid communication with the mixing volume defined by the delivery member. With reference to FIG. 27, the connector 4400 can be coupled to the delivery member 4500 by moving an end surface 4413 of the connector into the hub 4520 of the delivery member 4500. The fitting 4420 then couples to a flange of the hub 4520. In some embodiments, the fitting 4420 can be a swivel fitting that rotates relative to the connector 4400 to couple to the delivery member. In this way, the distal surface 4413 including the first outlet 4415 and the second outlet 4416 is within the mixing volume 4521 of the hub. In some embodiments, a portion of the first component and the second component can be delivered automatically in response to a user actuating a "priming" switch and / or trigger, as described above with respect to the system 3000.
[0155] After the delivery member couples to the connector, at 24, the second portion of the first component and the second portion of the second component are then delivered into the mixing volume. The second portion of the first component crosslinks with the second portion of the second component to form a hydrogel (i.e., the delivered biomaterial product) within the delivery member. In some embodiments, the hydrogel has a short gelation time and is delivered at a slow rate such that the hydrogel is fully formed within the mixing volume. In other embodiments, the formation of the hydrogel (i.e., the crosslinking reaction) may occur within the mixing volume and catheter portion such that the hydrogel is fully formed as it flows out of the delivery member. The method further includes delivering the hydrogel from the delivery member through the outlet portion of the delivery member at 25. In some embodiments, the first component and a portion of the second component may be delivered automatically in response to a user activating an "inject" switch and / or trigger, as described above with respect to system 3000.
[0156] In some embodiments, the hydrogel can be any of the hydrogels described herein and can be delivered into a body lumen, for example, in some embodiments, the hydrogel can be delivered into the vas deferens and form an occlusion therein to block sperm as a form of contraception.
[0157] In some embodiments, the delivery of the components can be controlled by any of the electronic control systems described herein. For example, in some embodiments, the components can be delivered at a rate within a predetermined rate range and / or at a driving force below a threshold driving force. In some embodiments, the hydrogel can be delivered into the body lumen in less than 30 seconds. In some embodiments, delivering the hydrogel from the delivery member includes delivering about 50 microliters to about 200 microliters in between about 5 seconds and about 20 seconds.
[0158] In some embodiments, the method can include performing a second injection (e.g., into a second body lumen of the patient) using the system and the same container assembly. In such embodiments, the method 20 can optionally include removing the first delivery member from the connector at 26. Thereafter, after removing the first delivery member, the connector can optionally be primed a second time at 27. The second priming can be performed by conveying a third portion of the first component to a first outlet of the connector and a third portion of the second component to a second outlet of the connector.
[0159] After the second priming, optionally at 28, a second delivery member is coupled to the connector to place the first outlet of the connector and the second outlet of the connector in fluid communication with the mixing volume defined by the second delivery member. After the second delivery member is coupled to the connector, at 29, a fourth portion of the first component and a fourth portion of the second component are then delivered into the mixing volume. The fourth portion of the first component crosslinks with the fourth portion of the second component to form a second hydrogel (i.e., a second delivered biomaterial product) within the second delivery member.
[0160] In some embodiments, any of the systems described herein can be used to deliver a biomaterial product into each of the patient's two vas deferens. After delivery, the biomaterial product can then occlude the lumen of the vas deferens to block the flow of sperm therethrough. Notably, the procedure can be completed using a single container assembly. This is advantageous because the ingredients used to form each of the delivered biomaterial products are prepared once for both injections. In addition, the single container assembly only needs to be loaded into the delivery device once. By reducing the number of steps, the procedure can be streamlined and performed more efficiently.
[0161] FIG. 33 is a flow diagram illustrating a method 30 of delivering a biomaterial product according to an embodiment, which is described below with reference to FIGS. 34-36. Although the method 30 is described in relation to the delivery system 4000, in other embodiments, the method 30 can be performed using any of the systems, delivery devices, and components described herein, such as, for example, the delivery systems 1000, 2000, and 3000 and / or delivery devices 1100, 2100, and 3100 described herein. In some embodiments, a cartridge assembly can be prepared prior to the delivery operation. For example, a first component can be prepared and loaded into a first container (or syringe), and a second component can be prepared and loaded into a second container (or syringe). Optionally, the container can then be placed into a cartridge (e.g., cartridge 4350). The method includes, at 31, coupling the container assembly to the delivery device. The container assembly includes the first component and the second component separate from the first component. In some embodiments, the container assembly can include a single container, similar to container assembly 2300 described above. The delivery device can be any of the delivery devices described herein and includes a drive assembly.
[0162] At 32, a first delivery member is inserted into the first body lumen. With reference to FIG. 34, the first delivery member can be a delivery member 4500, and the insertion can include inserting an end portion 4512 into the first vas deferens VD of the patient. After inserting the first delivery member, at 33, the first delivery member is coupled to a container assembly. In some embodiments, the system can be primed prior to coupling the first delivery member to the container assembly, as described above. With reference to FIG. 35, the first delivery member 4500 can be coupled to the container assembly by a connector 4400. The coupling can be completed by rotating at least one of the fitting 4420 or the delivery member 4500 relative to one another.
[0163] At 34, the delivery device is actuated to generate a first driving force by the drive assembly to convey the first portion of the first component and the first portion of the second component from the container assembly through the first delivery member. The first component crosslinks with the second component to form a first hydrogel within the first delivery member. Continuing conveying conveys the first hydrogel into the first body lumen. With reference to FIG. 36, the first hydrogel (identified as biomaterial product 3) is conveyed into the vas deferens VD, as shown by arrow GG. Delivery can be controlled as described herein to generate a desired volume and / or length of the first hydrogel within the vas deferens.
[0164] After the first actuation, the first delivery member is decoupled from the container assembly at 35. The first delivery member may optionally be removed and discarded. At 36, the second delivery member is inserted into the second body lumen. The second delivery member may be delivery member 4500, and the insertion may include inserting end portion 4512 into the patient's first vas deferens VD. After inserting the second delivery member, the second delivery member is coupled to the container assembly at 37.
[0165] At 38, the delivery device is actuated a second time to generate a second driving force by the drive assembly to convey the second portion of the first component and the second portion of the second component from the container assembly through the second delivery member. The first component crosslinks with the second component to form a second hydrogel within the second delivery member. Continuing the conveying conveys the second hydrogel into the second body lumen.
[0166] While in many instances it may not be desirable to deliver any substances other than therapeutic materials into the body, the systems described herein may be used to advantageously prime (or prepare) a blood vessel into which a biomaterial product is to be delivered. Similarly, in some embodiments, the method may include delivering a priming fluid (e.g., air, saline, or any other suitable inert fluid) into the target blood vessel prior to delivering the biomaterial product. Delivery of the priming fluid may prepare the body lumen by expanding (or enlarging) the body lumen, flushing out impurities, and / or by creating a coating on the walls that may improve the effectiveness of the delivered biomaterial product and aid in proper placement of the biomaterial product.
[0167] FIG. 37 is a flow diagram illustrating a method 40 of delivering a biomaterial product according to an embodiment, which is described below with reference to FIGS. 38 and 39. The method 40 can be performed using any of the systems, delivery devices, and components described herein, such as, for example, the delivery systems 1000, 2000, 3000, and 4000 and / or delivery devices 1100, 2100, 3100, and 4100 described herein. In some embodiments, the cartridge assembly can be prepared prior to the delivery operation. For example, a first component can be prepared and loaded into a first container (or syringe), and a second component can be prepared and loaded into a second container (or syringe). Optionally, the container can then be placed into a cartridge (e.g., cartridge 4350). The method includes, at 41, inserting an outlet portion of a delivery member into a body lumen. The delivery member can be any of the delivery members described herein (e.g., delivery member 4500) and can have an exit portion inserted into any body lumen, such as the patient's vas deferens VD. The delivery member is inserted such that the connecting portion (e.g., similar to hub 4520) is outside the body.
[0168] In some embodiments, the system may optionally be primed prior to coupling the first delivery member to the container assembly at 42. Priming the system (not to be confused with priming the vessel) may be accomplished by any of the methods described above. For example, in some embodiments, priming the system may include priming an outlet portion of the container assembly by conveying a portion of the first component from the container assembly to a first outlet of the container assembly and a portion of the second component from the container assembly to a second outlet of the container assembly.
[0169] After inserting the delivery member, a coupling portion of the delivery member is coupled to the container assembly at 43. The coupling is performed so as to retain a bolus of air within at least a portion of the delivery member. However, in other embodiments, a bolus of any fluid may be used to prime the blood vessel. For example, in some embodiments, a predetermined amount of saline solution may be placed into the delivery member (e.g., mixing volume 4521) prior to coupling the delivery member to the container assembly.
[0170] The method then includes conveying the first and second components into the delivery member at 44. The first component crosslinks with the second component to form a hydrogel within the delivery member. Conveying the first and second components into the delivery member also delivers a bolus of air into the body lumen through the outlet portion of the delivery member. For example, FIGS. 38 and 39 show cross-sectional views of a portion of a vas deferens VD into which a biomaterial product is implanted. FIG. 38 shows the cross-sectional shape of the lumen L before delivery of the bolus of air (or priming fluid). As shown, the cross-sectional shape is irregular and includes many sharp bends (i.e., areas of curved small radii). FIG. 39 shows the cross-sectional shape of the lumen L after delivery of the bolus of air (or priming fluid). As shown, delivery of the priming fluid expands the lumen L and reduces the irregularities and sharp bends in the lumen L. In this manner, priming of the vessel creates a vessel cross-section that will produce better adhesion and / or retention of the delivered biomaterial. After the first and second components are initially conveyed into the delivery member, the hydrogel is conveyed into the body lumen at 45 via the outlet portion of the delivery member.
[0171] FIG. 40 is a bar graph demonstrating the accuracy and precision of using a discretionary injection device that requires the user to press the thumb clip to inject versus an automatic injection device as described in an embodiment of the present invention. Both the automatic and discretionary devices have similar components, including a syringe, a plunger, a Y-connector, a delivery member (e.g., angiocatheter), and a polymeric material. A discretionary injection test (n=207) into synthetic model tubing by six users demonstrated high accuracy in plug volume, however, precision was low and users experienced clogging of the device 5% of the time. Meanwhile, the automatic device had high accuracy and precision for all implantations (n=28), with zero reported clogging. This reveals that the automatic device described herein provides an improvement and may enable users (i.e., physicians) to reliably implant biomaterials even in the presence of patient-to-patient variability. In particular, controlling the delivery of the implanted material by the device, rather than by the force generated by the user's hand, improves delivery performance. The volume displayed does not include the dead volume of the needle or catheter, but rather only the volume that flows out of the tip of the catheter or needle.
[0172] Figure 41 is a bar graph demonstrating the use and accuracy of the embodiments described herein. The automated device was able to deliver two-component polymer hydrogels in implantation volumes that corresponded precisely to the target delivery volumes (n=10). No clogging was observed in either group. The volumes shown do not include the dead volumes of the needle or catheter, but rather only the volumes that flowed out of the tip of the catheter or needle.
[0173] FIG. 42 is a bar graph demonstrating the use of an embodiment of the automated device to form different graft lengths (also known as plug lengths) into synthetic tubing (0.8 mm inner diameter). Plug lengths ranged from 1.5 cm to 8 cm depending on the injection volume. Following implantation, the plugs were subjected to a saline burst pressure test at 10 lbF (120x the in vivo pressure). The graph illustrates that plugs that were 1.5 cm long did not survive the burst pressure test, while plugs greater than 2 cm were able to withstand the burst pressure. This data highlights the importance of controlling the speed, flow rate, and / or driving force to ensure achieving the desired volume and / or length of delivered biomaterial.
[0174] 43-47 show a delivery system 5000, according to an embodiment. As described herein, the delivery system 5000 is configured to carry and combine multiple biomaterial components to form a biomaterial product that is delivered to a target location.
[0175] The system 5000 includes a delivery device 5100, a drive assembly 5150, an electronic control system 5200, a container assembly 5300, and a connector 5400. The delivery device 5100 includes a cover 5110, a drive assembly 5150, and a handle portion 5120. The handle portion 5120 may include a textured or perforated surface 5121 to enhance grip. Similar to the other container assemblies described above, the container assembly 5300 includes a first container 5301 and a second container 5302. The container assembly 5300 further includes a first end 5331 configured to couple to the connector 5400 and a second end 5332 including a flange portion 5343 configured to receive an input from the drive assembly 5150. The drive system 5150 is configured to drive the flange portion 5343, which in turn actuates the plunger 5340 to expel the first component from the first container 5301 and the second component from the second container 5302. Upon expulsion of the first and second components from the first container 5301 and second container 5302, respectively, the first and second components are carried to the connector 5400. The components can be mixed, crosslinked, and dispensed from the connector 5400 in the same manner as the other connectors described above.
[0176] The electronic control system 5200 is configured to control the actuation and output of the drive assembly 5150 and is operable to control the delivery characteristics of the delivery device 5100 in a manner similar to the other delivery devices and methods described above. The electronic control system 5200 includes one or more buttons 5230. In some embodiments, the one or more buttons 5230 include a first button 5231, a second button 5232, a third button 5233, and a fourth button 5234. The first, second, and third buttons 5231, 5232, 5233 are positioned above the handle portion 5120 to allow a user to utilize the first, second, and third buttons 5231, 5232, 5233 with their thumbs while gripping the handle portion 5120. A fourth button 5234 is located on the back of the handle portion 5120, allowing a user to utilize the fourth button 5234, for example, with an index finger while gripping the handle portion 5120. The electronic control system 5200 further includes an indicator 5220 that provides visual feedback to the user. For example, the indicator 5220 may include one or more lights 5221, 5222. The lights 5221, 5222 may illuminate to display different colors of light and / or different fixed or blinking patterns to provide visual feedback to the user or the operational status of the delivery device 5100. In some embodiments, the indicator 5220 may further include a display (not shown) that shows letters, numbers, or symbols to provide additional visual feedback to the user.
[0177] The first button 5231 is configured as a power button to turn the delivery device 5100 on and off. The second button 5232 is configured as a priming button to perform a priming operation (e.g., actuate the drive assembly 5150 to convey the first and second components into the connector 5400). For example, the delivery device 5100 is operable to perform any of the priming operations described herein. The third button 5233 is configured as an injection button to perform an injection operation (e.g., mix two components to form a biomaterial and dispense the biomaterial from the connector into the body lumen). For example, the delivery device 5100 is operable to perform any of the injection or delivery operations described herein. The fourth button 5234 is configured as a trigger button. For example, pressing either the second button 5232 or the third button 5233 may initiate the delivery device 5100 to perform a priming operation or an injection operation, respectively. The delivery device 5100 may confirm the selected operation, for example, by flashing one or more of the lights 5221, 5222 and / or glowing green. To confirm and proceed with the selected operation, the user presses the fourth button 5234. After pressing the fourth button 5234, the delivery device 5100 performs the selected operation.
[0178] In some embodiments, the electronic control system 5200 is coupled to a power source 5240 via an input or connector 5241 to provide power to the delivery device 5100. The delivery device 5100 may be fully powered by the power source 5240, partially powered by the power source 5240, and / or charged via the power source 5240. Digital and analog signals may also be transmitted to and from the delivery device 5100 via the connector 5241.
[0179] As generally shown in FIG. 45 , the cover 5110 includes a movable lid 5140 that surrounds the container assembly 5300 and / or secures the container assembly 5300 to the cover 5110. The movable lid 5140 can be opened by a hinge mechanism, opened by sliding a cover, and / or removed from the delivery device 5100 to access, install, and / or remove the container assembly 5300 from the interior area of the cover 5110. When the movable lid 5140 is in the open position and lifted off the delivery device 5100, the container assembly 5300 is accessible. In the open position, the interior area of the cover 5110 is exposed for the container assembly 5300 to be inserted into, mounted on, or removed from the cover 5110 of the delivery device 5100. For example, a new container assembly may be installed into the cover 5110 prior to a new procedure and removed from the cover 5110 once the procedure is completed. In some embodiments, the container assembly 5300 is a consumable part and the delivery device 5100 is a reusable part.
[0180] The movable lid 5140 and the delivery device 5100 may include hinges or complementary attached tabs (not shown) that removably secure the movable lid 5140 to the delivery device 5100 in the closed position. Additionally or alternatively, the movable lid 5140 and the delivery device 5100 may include complementary tracks, detents, and / or magnetic features (not shown) to removably secure the movable lid 5140 in the closed position.
[0181] As shown in FIG. 45 , the container assembly 5300 includes a cartridge 5350. The cartridge 5350 includes a first recessed portion 5351 for receiving the first container 5301 and the second container 5302 of the container assembly 5300. The cartridge 5350 further includes a second recessed portion 5352 for receiving and securing the connector 5400 to the cartridge 5350. The cartridge 5350 includes one or more ribs 5353 or bumpers 5354 to prevent the first and second containers 5301, 5302, and the connector 5400 from moving axially when installed on the cartridge 5350. The first recessed portion 5351 and the second recessed portion 5352 can be sized and shaped to provide a friction fit that prevents the container assembly 5300 and the connector 5400 from moving laterally.
[0182] On the side opposite the first recessed portion 5351 and / or the second recessed portion 5352 (e.g., the lower side of the cartridge 5350 in FIG. 45 ), the cartridge 5350 includes a mounting portion that secures and aligns the cartridge 5350 to the cover 5110 of the delivery device 5100. In some embodiments, a kit including the cartridge 5350 along with the container assembly 5300 and the connector 5400 is pre-mounted and assembled on the cartridge 5350 such that a user can mount the cartridge 5350 directly on the cover 5110 for ease of use and efficiency. Additionally, a separate alignment and calibration step is not required because the location of the container assembly 5300 relative to the cartridge 5350 is known and the cartridge 5350 couples to the cover 5110 along the axis of travel of the plunger 5340 at a predefined location on the cover 5110. Furthermore, when the cartridge 5350 is aligned on the cover 5110 via the mounting portion, the drive assembly 5150 can engage the plunger 5340 at a predetermined fixed position to inadvertently actuate the plunger 5340. Thus, the mounting portion automatically aligns and predictably orients the container assembly 5300 on the cover 5110 such that the drive assembly 5150 consistently engages the plunger 5340 at a predetermined fixed position without inadvertently actuating the plunger 5340. For example, the drive assembly 5150 may be placed in a retracted position (e.g., a fixed position described herein) such that the cartridge 5350 and the container assembly 5300 do not engage the drive assembly 5150 on the cover 5110 during installation. This prevents inadvertent actuation of the plunger 5340. Once the cartridge 5350 and container assembly 5300 are installed on the cover 5110, the drive assembly 5150 can perform priming and / or injection operations using known locations based on fixed positions as described herein, thereby eliminating the need for separate alignment or calibration procedures.
[0183] In some embodiments, the cartridge 5350 and container assembly 5300 are provided as a consumable part that can be quickly installed into and aligned with the sheath 5110 of the delivery device 5100.
[0184] 47-52 show a delivery system 6000, according to an embodiment. As described herein, the delivery system 6000 is configured to carry and combine multiple biomaterial components to form a biomaterial product that is delivered to a target location.
[0185] The system 6000 includes a delivery device 6100, a drive assembly 6150, an electronic control system 6200, a container assembly 6300, and a connector 6400. The delivery device 6100 includes a shroud 6110, a drive assembly 6150, and a handle portion 6120. Similar to the other container assemblies described above, the container assembly 6300 includes a first container 6301 and a second container 6302. The container assembly 6300 further includes a first end 6331 configured to couple to the connector 6400 and a second end 6332 including a flange portion 6343 configured to receive an input from the drive assembly 5150. The drive system 6150 is configured to drive the flange portion 6343, which in turn actuates the plunger 6340 to expel the first component from the first container 6301 and the second component from the second container 6302 via the flange portion 6343. Release of the first and second components from the first and second containers 6301 and 6302, respectively, carries the first and second components to the connector 6400. The components can be mixed, crosslinked, and dispensed from the connector 6400 in the same manner as the other connectors described above.
[0186] The electronic control system 6200 is configured to control the actuation and output of the drive assembly 6150 and is operable to control the delivery characteristics of the delivery device 6100 in the same manner as the other delivery devices and methods described above. The electronic control system 6200 includes one or more buttons 6230. A first button 6231 is located at the base of the handle portion 6120. A second and third button 6232, 6233 are located above the handle portion 6120, and a user can access the second and third buttons 6232, 6233 with their thumbs while gripping the handle portion 6120. A fourth button 6234 is located at the back of the handle portion 6120, and a user can access the fourth button 6234 with their index finger, for example, while gripping the handle portion 6120. The electronic control system 6200 further includes a first indicator 6221 and a second indicator 6222 that provide visual feedback to the user. For example, the first indicator 6221 and the second indicator 6222 may include a backlight that illuminates a symbol or logo associated with the second button 6232 and the third button 6233, respectively.
[0187] The first button 6231 is configured as a power button to turn the delivery device 6100 on and off. The second button 6232 is configured as a priming button to perform a priming operation (e.g., actuating the drive assembly 6150 to convey the first and second components into the connector 6400). The delivery device 6100 is operable to perform any of the priming operations described herein. The third button 6233 is configured as an injection button to initiate an injection operation (e.g., mixing two components to form a biomaterial and dispensing the biomaterial into a body lumen). The delivery device 6100 is operable to perform any of the injection or delivery operations described herein. The fourth button 6234 may be programmed or assigned as a trigger button. For example, pressing either the second button 6232 or the third button 6233 may prepare the delivery device 6100 to perform a priming operation or an injection operation, respectively. The delivery device 6100 may confirm the selected operation by illuminating or flashing a backlit indicator 6221, 6222 associated with the second button 6232 or the third button 6233. To confirm and proceed with the selected operation, the user presses the fourth button 6234. After pressing the fourth button 6234, the delivery device 6100 performs the selected operation. In an alternative embodiment, pressing the second button 6232 initiates a priming operation, pressing the third button 6233 recreates the mixing of the two components, pressing the third button 6233 initiates mixing of the two components, and pressing the fourth button 6234 initiates an injection operation. In some embodiments, the first button 6231 (or any of the power buttons described herein) can initiate a start-up procedure that cycles the drive assembly 6150 through its entire range of motion, i.e., the range of motion required for the desired operation, to verify that the drive components of the drive assembly 6150 are functioning properly.If a fault is detected during the start-up procedure, the electronic control system 6200 (or any other electronic control system described herein) may prevent the priming or injection operation from being performed.
[0188] As shown in FIGS. 49 and 51 , the cover 6110 includes a first retainer portion 6116, a second retainer portion 6117, and a third retainer portion 6118. At least one of the first retainer portion 6116, the second retainer portion 6117, or the third retainer portion 6118 is configured to secure the container assembly 6300 to the cover 6110. In one embodiment, the first retainer portion 6116 and the second retainer portion 6117 include a C-shaped or U-shaped cross-section configured to grip the outer surfaces of the first container 6301 and the second container 6302. The third retainer portion 6118 extends from a base surface of the cover 6110 and is adjacent to the second end 6332 of the container assembly 6300. The third retainer portion 6118 prevents the container assembly 6300 from moving axially. The location of the retainer portion 6118 allows the container assembly 6300 to be mounted at a predefined location on the cover 6110 along the axis of travel of the plunger 6340. The first and second retainer portions 6116, 6117 further prevent lateral movement of the container assembly 6300 relative to the axis of travel of the plunger 6340. As such, the container assembly 6300 can be predictably mounted on the cover 6110 such that the drive assembly 6150 consistently engages the plunger 6340 at a predetermined home position without inadvertently actuating the plunger 6340. For example, the drive assembly 6150 may be placed in a retracted position (e.g., a home position described herein) such that the container assembly 6300 does not engage the drive assembly 6150 on the cover 6110 during installation. This prevents inadvertent actuation of the plunger 6340. Once the container assembly 6300 is installed on the cover 6110, the drive assembly 6150 can perform priming and / or injection operations using known locations based on fixed positions as described herein, thereby eliminating the need for separate alignment or calibration procedures.
[0189] 53-56 show a delivery system 7000, according to an embodiment. As described herein, the delivery system 7000 is configured to carry and combine multiple biomaterial components to form a biomaterial product that is delivered to a target location.
[0190] The system 7000 includes a delivery device 7100, an electronic control system 7200, a container assembly 7300, and a connector 7400. The delivery device 7100 includes a shroud 7110, a drive assembly 7150, and a handle portion 7120. As shown in FIGS. 53 and 54 , the shroud 7110 extends from a proximal end portion 7111 to a distal end portion 7112. The handle portion 7120 extends from the distal end portion 7112. The handle portion 7120 can include a textured or perforated surface 7121 to improve grip. The handle portion 7120 can further include a wrist support portion 7122 to further improve stability of the delivery device 7100 in a user's hand during operation.
[0191] Similar to the other container assemblies described above, container assembly 7300 includes a first container 7301 and a second container 7302. Container assembly 7300 further includes a first end 7331 configured to couple to connector 7400 and a second end 7332 including a flange portion 7343 configured to receive an input from drive assembly 7150. Drive system 7150 is configured to drive flange portion 7343, which in turn actuates plunger 7340 to expel a first component from first container 7301 and a second component from second container 7302. Upon expulsion of the first and second components from first container 7301 and second container 7302, respectively, the first and second components are conveyed to connector 7400. The components can be mixed, crosslinked, and dispensed from connector 7400 in the same manner as the other connectors described above.
[0192] The electronic control system 7200 is configured to control the actuation and output of the drive assembly 7150 and is operable to control the delivery characteristics of the delivery device 7100, similar to the other delivery devices and methods described above. The electronic control system 7200 includes one or more buttons 7230. A first button 7321 is positioned on the proximal end portion 7111 of the shroud 7110.
[0193] As shown in FIGS. 53 and 56 , the second and third buttons 7232, 7233 are positioned above the handle portion 7120 and on either side of the cover 7110. The fourth button 7234 is positioned on the handle portion 7120 to allow a user to utilize the fourth button 7234 with a thumb, for example, while gripping the handle portion 7120. The electronic control system 7200 further includes one or more visual indicators 7221, 7222, 7223. For example, the one or more visual indicators 7221, 7222, 7223 may be LED indicators that provide visual feedback to the user or the operational status of the delivery device 7100. In some embodiments, an operating or task light 7224 is provided at the distal end portion 7112 of the cover 7110 to further illuminate the patient's surgical area. In some embodiments, the task light 7224 may be activated by pressing the first button 7231 or by a separate light button (not shown).
[0194] The first button 7231 is configured as a power button to turn the delivery device 7100 on and off. The second button 7232 is configured as a priming button to initiate a priming operation (e.g., actuating the drive assembly 7150 to convey the first and second components into the connector 7400). The delivery device 7100 is operable to perform any of the priming operations described herein. The third button 7233 is configured as an injection button to initiate an injection operation (e.g., mixing two components to form a biomaterial and dispensing the biomaterial into a body lumen). The delivery device 7100 is operable to perform any of the injection or delivery operations described herein. The fourth button 7234 may be programmed or assigned as a trigger button. For example, pressing either the second button 7232 or the third button 7233 may prepare the delivery device 7100 to perform a priming operation or an injection operation, respectively. The delivery device 7100 may confirm the selected operation by lighting or flashing one or more of the LED indicators 7221, 7222, 7223. To confirm and proceed with the selected operation, the user presses the fourth button 7234. After pressing the fourth button 7234, the delivery device 7100 performs the selected operation.
[0195] As shown in FIG. 55 , the cover 7110 includes a first retainer portion 7116, a second retainer portion 7117, and a third retainer portion 7118. At least one of the first retainer portion 7116, the second retainer portion 7117, or the third retainer portion 7118 is configured to secure the container assembly 7300 to the cover 7110. In one embodiment, the first retainer portion 7116 and the second retainer portion 7117 include a C-shaped or U-shaped cross-section configured to grip the outer surfaces of the first container 7301 and the second container 7302. The third retainer portion 7118 extends from a base surface of the cover 7110 and is adjacent to the second end 7332 of the container assembly 7300. The third retainer portion 7118 prevents the container assembly 7300 from moving axially. The location of the retainer portion 7118 allows the container assembly 7300 to be mounted at a predefined location on the shroud 7110 along the axis of travel of the plunger 7340. The first and second retainer portions 7116, 7117 further prevent lateral movement of the container assembly 7300 relative to the axis of travel of the plunger 7340. As such, the container assembly 7300 can be predictably mounted on the shroud 7110 such that the drive assembly 7150 is in a known position relative to the plunger 7340. For example, the drive assembly 7150 may be placed in a retracted position (e.g., a home position as described herein) such that the container assembly 7300 does not engage the drive assembly 7150 during mounting on the shroud 7110. This prevents the plunger 7340 from being inadvertently actuated. Once the container assembly 7300 is installed on the cover 7110, the drive assembly 7150 can perform priming and / or injection operations using a known location based on a fixed position as described herein, thereby eliminating the need for a separate alignment or calibration procedure. As described herein, the system 7000 may include sensors that detect whether the container assembly 7300 and / or connector 7400 are properly seated and connected prior to initiating a priming or injection operation.
[0196] With reference to Figures 57-60, experimental test results in dog and rabbit vas deferens are now discussed. As one skilled in the art would appreciate, human and dog vas deferens are similar in many ways, including wall thickness and overall vessel length, as well as anatomical similarities. In contrast, rabbit vas deferens has thinner vessel walls, a different anatomical structure, and is shorter than human vas deferens. As described herein, controlled biomaterial formation and delivery to a target site is critical to prevent damage to the target site or surrounding area. Controlled biomaterial formation and delivery to a target site is also important to ensure that the delivered biomaterial is effective for the intended application. For example, biomaterials such as hydrogels can be delivered into the vas deferens to block sperm as a form of contraception.
[0197] As shown in Figure 57, a cross section of a normal dog vas deferens 8000 is shown. The dog vas deferens 8000 includes a lumen 8100 and smooth muscle 8200 surrounding the lumen 8010. In one test case, the system 4000 was configured to mix the components in the cartridge 4350 and deliver the formed hydrogel via the catheter 4510 to the dog's vas deferens (not shown) at a rate of 400 μL / min for a total delivery volume of 200 μL. In this test case, no vascular damage or hydrogel leakage was observed, and delivery and implantation of the formed hydrogel into the dog's vas deferens was effective (azoospermia upon subsequent semen collection after implantation).
[0198] By comparison, in another test case, system 4000 was configured to mix ingredients in cartridge 4350 and deliver the formed hydrogel 9300 to a dog's vas deferens 9000 via catheter 4510 at a rate of 3200 μL / min for a total delivery volume of 75 μL. As shown in FIGS. 58 and 59, the dog's vas deferens 9000 had observable tissue damage to the lumen 9100 and surrounding muscle 9200 after delivery of the hydrogel 9300. By way of another comparison, in one test case, system 4000 was configured to mix ingredients in cartridge 4350 and deliver the formed hydrogel to a rabbit's vas deferens 10000 via catheter 4510 at a rate of 400 μL / min for a total delivery volume of 200 μL. As shown in Figure 60, the rabbit vas deferens 10000 was damaged with rupture of the outer vessel wall 10100 and leakage of the formed hydrogel 10200. In view of the above, application of the same injection parameters may result in effective implantation in the dog vas deferens while causing damage to the rabbit vas deferens. Varying the delivery rate and / or injection force for the same type of target site (e.g., two different dog vas deferens) may result in dramatically different outcomes, effective implantation in one scenario and damage to the vas deferens in the other.
[0199] As demonstrated by the experimental test results above, precise control over the force applied and the speed at which at least the formed biomaterial is delivered as it is ejected into the target site can be achieved by the systems and methods described herein and is critical to successfully delivering the biomaterial to the target site without damaging the site or surrounding areas.
[0200] While a machine-readable storage medium (e.g., in electronic control system 2200) is shown as a single medium in an example implementation, the term "machine-readable storage medium" should be considered to include a single or multiple media (e.g., a centralized or distributed database and / or associated caches and servers) that store one or more sets of instructions. The term "machine-readable storage medium" should also be considered to include any medium that can store or encode a set of instructions for execution by a machine, causing the machine to perform any one or more of the methodologies of this disclosure. Thus, the term "machine-readable storage medium" should be considered to include, but is not limited to, solid-state memory, optical media, and magnetic media.
[0201] The present disclosure also relates to an apparatus for performing the operations herein. This apparatus may be specially constructed for the intended purposes or may comprise a general-purpose computer selectively activated or reconfigured by a computer program stored in the computer. Such a computer program may be stored in a computer-readable storage medium, such as any type of disk, including but not limited to floppy disks, optical disks, CD-ROMs, Universal Serial Bus (USB) flash drives, and magneto-optical disks, read-only memory (ROM), random access memory (RAM), EPROM, EEPROM, magnetic or optical cards, or any type of medium suitable for storing electronic instructions, each coupled to a computer system bus.
[0202] Various general purpose systems may be used with programs in accordance with the teachings herein, or it may prove convenient to construct more specialized apparatus to carry out the methods. The structure of a variety of these systems will appear as set forth in the description that follows. In addition, the present disclosure is not described with reference to any particular programming language. It will be understood that a variety of programming languages may be used to implement the teachings of the present disclosure as described herein.
[0203] The present disclosure may be provided as a computer program product, i.e., software, which may include a machine-readable medium having stored thereon instructions that may be used to program a computer system (or other electronic device) to perform processes according to the present disclosure. A machine-readable medium includes any mechanism for storing information in a form readable by a machine (e.g., a computer). For example, machine-readable (e.g., computer-readable) media includes machine (e.g., computer) readable storage media, such as, for example, read-only memory ("ROM"), random access memory ("RAM"), magnetic disk storage media, optical storage media, flash memory devices, and the like.
[0204] Some embodiments described herein relate to computer storage products with non-transitory computer-readable media (which may also be referred to as non-transitory processor-readable media) having instructions or computer code for performing various computer-implemented operations. The computer-readable media (or processor-readable media) is non-transitory in the sense that it does not include a transitory propagating signal itself (e.g., a propagating electromagnetic wave that carries information on a transmission medium such as space or cable). The media and computer code (which may also be referred to as code) may be designed and constructed for one or more specific purposes. Examples of non-transitory computer-readable media include, but are not limited to, magnetic storage media such as hard disks, floppy disks, and magnetic tapes; optical storage media such as compact disks / digital video disks (CD / DVD), compact disk read only memory (CD-ROM), universal serial bus (USB) flash drives, and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices specifically configured to store and execute program code, such as application specific integrated circuits (ASICs), programmable logic devices (PLDs), read only memory (ROM), and random access memory (RAM) devices.
[0205] Examples of computer code include, but are not limited to, microcode or microinstructions, e.g., machine instructions generated by a compiler, code used to generate a web service, and files containing higher level instructions executed by a computer using an interpreter. For example, embodiments may be implemented using an imperative programming language (e.g., C, Fortran, etc.), a functional programming language (Haskell, Erlang, etc.), a logic programming language (e.g., Prolog), an object-oriented programming language (e.g., Java, C++, etc.), or other suitable programming language and / or development tool. Further examples of computer code include, but are not limited to, control signals, encryption code, and compression code.
[0206] Several embodiments have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the present invention. In addition, the logic flows depicted in the figures do not require the particular order or sequence shown to achieve desirable results. In addition, other steps may be provided or removed from the described flows, and other components may be added to or removed from the described systems. Accordingly, other embodiments are within the scope of the following claims.
[0207] Although various embodiments of the present invention have been described above, it should be understood that they have been presented by way of example, not limitation. Where the above method shows certain events occurring in a particular order, the order of certain events may be modified. In addition, some of the events may occur simultaneously, in parallel processes when possible, or sequentially as described above. Any of the components and subcomponents described herein may be included in any of the embodiments, if not mutually exclusive. For example, in some embodiments, the device may be capable of performing one or more injections, such as delivering two biomaterials from the same device into the same patient. In some embodiments, the device performs a single priming step and a single injection, a single priming step and multiple injections, multiple priming steps and a single injection, multiple priming steps and multiple injections, multiple priming steps and multiple injections. The priming and injection steps may occur in a predefined order or in any order. The priming step may include the same or different volumes. If multiple injections are performed, the injections may have the same or different volumes each time.
[0208] In some embodiments, the device is used to inject a biomaterial formed from one or more precursors, e.g., two macromer solutions that crosslink with each other to form a hydrogel material. The device injects the solutions into the body such that the solutions form a hydrogel in situ. In some embodiments, the device is used to inject a biomaterial formed, e.g., a crosslinked hydrogel, into the body. Once injected, the hydrogel may continue to gel and / or crosslink in situ, or may be completely gelled or crosslinked by the time it exits the device. In this regard, the device facilitates the merging or mixing of two or more different solutions into a single stream.
[0209] In some embodiments, the device is a handheld device with a screen similar to a cystoscope. The housing of the device is designed to include a grip for the user to hold the device, a trigger, and buttons including power on and off buttons, a priming button, and an injection button. For example, the device is configured for the user to press the button to perform an injection. In some embodiments, the trigger controls the actuation (piston) of the syringe plunger, thereby controlling the volume dispensed. In some embodiments, the volume is dependent on the force exerted on the trigger. In some embodiments, the actuation of the syringe plunger is preset so that a consistent amount of volume is pushed out of the device regardless of the force the user applies on the trigger.
[0210] In some embodiments, the device includes one or more springs to apply the correct amount of pressure. The one or more springs can be reused by tensioning them. The one or more springs control the movement of a piston, actuator rod, or similar device to exert pressure on the syringe. By setting a specific tension level on the one or more springs, a precise force or pressure can be adjusted.
[0211] In some embodiments, the type and size of syringe selected for the device will affect the injection parameters and the biomaterial extruded. In some embodiments, the syringe material is glass, plastic, or a combination of both. The syringe can be lubricated or non-lubricated. In some embodiments, the syringes encompass about 0.1 mL to 100 mL in volume. For example, the syringes can be 0.5 cc, 1 cc, 2 cc, 5 cc, 10 cc, 20 cc, 50 cc, and / or 100 cc syringes. The inner diameter of the syringe can range from about 0.2 mm to 50 mm. For example, a 1 cc plastic BD syringe may be 4.64 mm in diameter. The cylindrical cross-sectional area can range from 0.000026 to 1.5 in 2In some embodiments, the plunger can be selected for a particular application based on different attributes including, for example, the manufacturer selected, volume, length, inner diameter, and lubrication. The plunger can be lubricated or non-lubricated and made from synthetic rubber, natural rubber, thermoplastics, and / or elastomers. In some embodiments, the syringe can be locked into a holder, also referred to as a chassis. In one aspect, the syringe can be loaded or contained within a cassette style syringe holder, which can be disposed of after use.
[0212] In one embodiment, the device includes a Y-connector (also known as a blending connector) that includes a channel through which the solutions flow. For example, manufacturers of Y-connectors include, but are not limited to, Nordson Medical (Micromedics), Medmix, and Sulzer. In one embodiment, the channels of the Y-connector do not promote mixing of the precursor solutions. Therefore, the solutions may merge or mix within the needle and / or catheter hub. In some embodiments, a dual lumen catheter or needle is attached to the Y-connector to prevent mixing or mixing of any solutions within the device. In some embodiments, the Y-connector is attached to a syringe(s) on one end.
[0213] In some embodiments, the device includes tubing that extends the distance from the syringe in the device to the Y-connector and / or the vascular catheter / needle. For example, manufacturers of such tubing include, but are not limited to, Zeus, Medline, and Cook Medical. In some embodiments, mixing of the two solutions occurs within the extended tubing. In some embodiments, mixing does not occur within the tubing. In some embodiments, a mixing chamber is attached to the Y-connector such that the solutions merge or mix within the mixing chamber after exiting the Y-connector. In some embodiments, the mixing chamber includes several mixing elements that determine the degree of mixing, such as 1 to 20 mixing elements. In some embodiments, a needle and / or catheter is attached to the mixing chamber.
[0214] In some embodiments, the device includes a catheter or needle, or a combination of both, by which the biomaterial can be extruded. The catheter or needle, or combination, is selected based on the desired application, the location of implantation, the chemical properties (e.g., viscosity) of the biomaterial, and the desired injection volume, speed, and force. The needle and / or catheter is configured to deliver the biomaterial subcutaneously, percutaneously, or intravaginally. In some embodiments, the device includes a needle-covered catheter or a catheter-covered needle. The maximum needle size / gauge is determined by the lumen of the vessel, duct, or organ that will receive the external stimulus, and as a result, the exact catheter, needle, or instrument size is not critical as long as it is of the appropriate shape and size for a particular application. The gauged needle and / or catheter can have a diameter ranging between about 100 um and 5 mm, including, for example, 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1.0 mm, 1 mm, 2 mm, 3 mm, 4 mm, or 5 mm. In some embodiments, the needle diameter is preferably between 0.3 mm and 1 mm. In some embodiments, the needle and / or catheter size is between about 6 gauge and 34 gauge, such as, for example, about 10 gauge to 34 gauge, or about 15 gauge to 32 gauge, or about 20 gauge to 26 gauge, or about 22 gauge to 26 gauge. In some embodiments, the needle size is between about 21 gauge and 31 gauge. In some embodiments, the needle can be extra thin walled (XXTW), extra thin walled (XTW), thin walled (TW), or regular walled (RW). For example, standard needle sizes are readily available, such as at http: / / www.sigmaaldrich.com / chemistry / stockroom-reagents / learning-center / technical-library / needle-gauge-chart.html. In some embodiments, a needle is used to introduce a secondary catheter into the lumen of a blood vessel.In one aspect, the needle or catheter can be between about 0.1 and 15 inches in length, preferably about 0.5 to 10 inches in length, such as about 0.8 to 5 inches, or about 0.4 to 1 or 2 or 3 inches in length. In some embodiments, the needle is echogenic or visible by ultrasound.
[0215] In some embodiments, the device is configured to operate with a dead volume, depending on the components used in the device. For example, the needle, catheter, and / or Y-connector are configured to provide a dead volume of about 10-1,000 μL. In some embodiments, the device is configured to operate with one or more start-stop cycles, one or more priming steps, and one or more implantations. For example, the device may have one, two, three, four, five, etc. start-stop cycles. In some embodiments, one step is used to prime the Y-connector, needle / catheter, and / or expansion tubing with precursor solution(s) to eliminate dead volume prior to injection of the biomaterial.
[0216] In some embodiments, the device is configured to inject a combination of three or more solutions or materials. The device is configured to mix any of the components, for example, two components may be mixed in the device, but the third component is not mixed. In some embodiments, all three components can be fused at the same location, such as in a Y-connector, or a needle / catheter hub, or expansion tubing. In some embodiments, the device includes a subsystem that allows for the introduction of fluids through the catheter system. In some embodiments, the device includes a fluid reservoir, or a separate fluid reservoir is fluidly connected to the device.
[0217] In some embodiments, the device is configured to deliver one or more combinations of different states of matter, such as solids, liquids, and gases, in any combination or sequence required. In some embodiments, the device delivers air through the needle / catheter / tubing followed by injection of multiple solutions. In another aspect, the device can deliver a liquid, such as saline or water for injection, followed by injection of a biomaterial. In one embodiment, the biomaterial extruded from the device is a hydrogel.
[0218] In some embodiments, the operating parameters of the device are optimized to provide consistent and / or controlled injection. These parameters include, but are not limited to, injection speed, volume injected, peak extrusion force, peak pressure in the syringe, distance the plunger travels, plunger speed, and plunger acceleration. When the operating parameters are altered for a particular application, the resulting injection and delivery of the biomaterial is altered. For example, the chemical, mechanical, and / or biological properties of the biomaterial (e.g., hydrogel or graft) can be altered based on the operating parameters, including, but not limited to, the length, width, and volume of the graft, the gelation rate of the graft, the shape of the graft, and how the graft reacts with the surrounding tissue. The length of the graft can directly affect the effectiveness of the device, such as for occlusion of the vas deferens for male contraception.
[0219] In some embodiments, the infusion rate ranges from about pL / min to 150 mL / min, more preferably 1-10,000 μL / min.
[0220] In some embodiments, the speed of injection is constant (not adjustable by the user) or not constant (adjustable). In some embodiments, the time is constant (not adjustable) or not constant (adjustable). Thus, the speed and / or length of time, or both, can be manipulated or set by the user to precisely control the injection volume. In one embodiment, the injected volume may range from 1 μL to 100 mL. In applications where the biomaterial is being implanted into a tube, blood vessel, or tissue that has size and / or diameter limitations, smaller volumes ranging from about 1 μL to 1,000 μL may be more preferred. The injection volume may be optimized to prevent rupture of the tissue or blood vessel. To occlude the vas deferens (ID ranging from about 0.5 to 0.8 mm), the preferred injection volume is about 1 μL to 200 μL.
[0221] In some embodiments, the peak extrusion force that the device needs to exert on the syringe plunger ranges from about 0.1 to 20 lbF. The force required depends on factors including, but not limited to, the viscosity of the solution, the type of syringe (e.g., manufacturer, length, inner diameter), the plunger, lubrication of the syringe and / or plunger, and the inner diameter of the needle. In some embodiments, the peak extrusion force is below 10 lbF. In some embodiments, the peak pressure of the syringe(s) ranges from about 0.1 to 20 mmHg. In some embodiments, the distance the plunger travels ranges from about 0.1 to 20 cm. In some embodiments, the plunger travels at a speed ranging from 0.1 to 10 mm / sec.
[0222] In some embodiments, the apparatus is configured to add a solvent (e.g., dissolving liquid) to the powder (e.g., polymer) within the device prior to the priming or injection step. For example, a container such as a syringe, vial, or ampoule containing the polymer powder is loaded into a groove within the apparatus, and upon pressing a button and / or trigger, the apparatus fills the container with the solution to dissolve the powder. In some embodiments, a carrier liquid is added to the solid or dehydrated body prior to delivery. In some embodiments, dissolution or hydration of the dehydrated body with the carrier liquid is initiated by a user pressing a button, switch, or trigger, after which the user can perform the priming and injection steps. In some embodiments, after mixing the solid and carrier solvent, the apparatus is configured to degas or remove air generated from the mixture of the liquid and solid before performing the priming and / or injection steps.
[0223] In some embodiments, the biomaterial may include polystyrene, neoprene, polyetheretherketone (PEEK), carbon reinforced PEEK, polyphenylene, polyetherketoneketone (PEKK), polyaryletherketone (PAEK), polyphenylsulfone, polysulfone, polyurethane, polyethylene, low density polyethylene (LDPE), linear low density polyethylene (LLDPE), high density polyethylene (HDPE), polypropylene, polyetherketoneetherketoneketone (PEKEKK), nylon, polytetrafluoroethylene (PTFE or TEFLON®), TEFLON® TFE (tetrafluoroethylene), polyethylene terephthalate (PET or PETE), TEFLON® FEP (fluorinated ethylene propylene), TEFLON® PFA (perfluoroalkoxyalkane), and / or fluoropolymers such as polymethylpentene (PMP) styrene maleic anhydride, styrene maleic acid (SMA), polyurethane, silicone, polymethyl methacrylate, polyacrylonitrile, poly(carbonate- urethane), poly(vinyl acetate), nitrocellulose, cellulose acetate, urethane, urethane / carbonate, polylactic acid, polyacrylamide (PAAM), poly(N-isopropylacrylamine) (PNIPAM), poly(vinyl methyl ether), poly(methylene oxide), poly(ethyl(hydroxyethyl)cellulose), poly(2-ethyloxazoline), polylactic acid (PLA), polyglycolic acid (PGA), poly(lactic acid-co-glycolide) (PLGA), poly(e-caprolactone), polydiaxanone one), polyanhydrides, trimethylene carbonate, poly(β-hydroxybutyric acid), poly(g-ethyl glutamic acid), poly(DTH-iminocarbonate), poly(bisphenol A iminocarbonate), poly(orthoesters) (POE), polycyanoacrylates (PCA), polyphosphazenes, polyethylene oxides (PEO), polyethylene glycols (PEG) or any of their derivatives, polyacrylic acid (PAA), polyacrylonitrile (PAN), polyvinyl acrylate (PVA), polyvinylpyrrolidone (PVP),Polyglycolic acid-lactic acid (PGLA), poly(2-hydroxypropyl methacrylamide) (pHPMAm), poly(vinyl alcohol) (PVOH), PEG diacrylate (PEGDA), poly(hydroxyethyl methacrylate) (pHEMA), N-isopropylacrylamide (NIPA), polyoxazoline (POx), poly(vinyl alcohol) poly(acrylic acid) (PVOH-PAA), collagen, silk, fibrin, gelatin, hyaluron, cellulose, chitin, dextran, casein, albumin, ovalbumin, heparin sulfate, starch, agar, heparin, alginate, fibronectin, fibrin, keratin, pectin, elastin, ethylene vinyl acetate, ethylene vinyl alcohol (EVOH), polyethylene oxide, PLLA or PlLA (poly(L-lactide) or poly(L-lactic acid)), poly(D,L-lactic acid), poly(D,L-lactide), polydimethylsiloxane The polymers may include one or more of the following: natural or synthetic monomers, polymers, or copolymers; biocompatible monomers, polymers, or copolymers, such as poly(isopropyl acrylate) (PIPA), polyethylene vinyl acetate (PEVA), PEG styrene, polytetrafluoroethylene RFE such as TEFLON® RFE or KRYTOX® RFE, fluorinated polyethylene (FLPE or NALGENE®), methyl palmitate, temperature responsive polymers such as poly(N-isopropylacrylamide) (NIPA), polycarbonate, polyethersulfone, polycaprolactone, polymethyl methacrylate, polyisobutylene, nitrocellulose, medical grade silicones, cellulose acetate, cellulose acetate butyrate, polyacrylonitrile, poly(lactide-co-caprolactone (PLCL), and / or chitosan.
[0224] In some embodiments, the dissolving solution for the polymer component(s) may be an aqueous buffer (pH range 1-14) of phosphate, citrate, acetate, histidine, lactate, tromethamine, gluconate, aspartate, glutamate, tartrate, succinate, malic acid, fumaric acid, alpha-ketoglutaric acid, and / or carbonate. Non-aqueous solvents include dimethyl isosorbide, glycofuro 75, PEG 200, diglyme, tetrahydrofurfuryl alcohol, ethanol, acetone, solketal, glycerol formal, dimethyl sulfoxide, propylene glycol, ethyl lactate, N-methyl-2-pyrrolidone, dimethylacetamide, methanol, isopropanol, 1,4-butanediol, ethyl acetate, toluene, acetonitrile. In some embodiments, upon dissolving the polymer components, the viscosity of the solution(s) constituting the biomaterial may range from 0.1 to 250,000 cP. The density of the solution may range from 0.1 to 20,000 kg / m3. The temperature during extrusion may range from 2 to 45° C. The pH of the solution(s) may range from 1 to 14. The ionic strength of the solution(s) may range from 1 nM to 70 M.
[0225] In some embodiments, when two components are injected to form a biomaterial, the ratio of the components may vary, such as 1:1, 1:1, 1:2, 3:1, 1:3, 4:1, 1:4, and up to 10:1 or 1:10. The rate of gelation of the biomaterial may range from about 0.001 seconds to 60 minutes. The length of the formed biomaterial may range from about 0.1 to 60 cm. The volume of the formed biomaterial may range from about 0.001 to 100 mL.
[0226] In some embodiments, the biomaterial swells within the implantation space to lock or secure its placement. For example, a biomaterial in the form of a hydrogel may swell to about 1.5-10 times its initial volume. In some embodiments, the extruded biomaterial conforms to the space into which it is injected. In some embodiments, the swelling of the biomaterial does not change the volume within the implantation space, or it otherwise shrinks to conform to the volume of the implantation space. In some embodiments, the device injects a preformed biomaterial (which does not crosslink, form, or gel in situ). Upon injection, the biomaterial may or may not react with the implantation space. If a reaction occurs, it may be covalent or non-covalent. In some embodiments, the biomaterial reacts by adhering within the implantation space.
[0227] Although electronic control system 2200 is shown to include certain modules, in other embodiments, electronic control system 2200 (or any of the electronic control systems described herein) can include different modules or components than those shown in Figures 8 and 9. For example, in some embodiments, any of the electronic control systems described herein can include any other suitable modules, such as, for example, a network module. The network module can facilitate communication between the electronic control system and other remote computing devices over a network (e.g., the Internet).
[0228] Although various embodiments have been described as having certain combinations of features and / or components, other embodiments can have any combination of features and / or components from any of the embodiments, as appropriate. For example, any of the devices shown and described herein can include an electronic control system similar to electronic control system 2200 as described herein.
Claims
1. a cover configured to receive at least a portion of a container assembly, the container assembly including a first container containing a first component and a second container containing a second component, the first container and the second container configured to couple to a connector, the container assembly including a first plunger and a second plunger; a delivery member configured to be coupled to the connector to provide a first outlet of the connector and a second outlet of the connector in fluid communication with a mixing volume defined by the delivery member; a drive assembly configured to operably couple to the container assembly, priming the connector by conveying a first amount of the first component from the container assembly to a first outlet of the connector and conveying a first amount of the second component from the container assembly to a second outlet of the connector; conveying the second amount of the first component and the second amount of the second component into the mixing volume such that the second amount of the first component crosslinks with the second amount of the second component to form a hydrogel within the delivery member; a drive assembly configured to convey the hydrogel from the delivery member through an outlet portion of the delivery member.
2. the container assembly includes a first container containing the first component and a second container separate from the first container containing the second component; The apparatus of claim 1 , wherein the connector includes a first inlet connected to the first container and a second inlet connected to the second container.
3. the delivery member is a first delivery member and the hydrogel is a first hydrogel; The drive assembly includes: priming the connector by delivering a third amount of the first component to the first outlet of the connector and a third amount of the second component to the second outlet of the connector after the first delivery member is removed from the connector; 3. The device of claim 1 or 2, configured to deliver a fourth amount of the first component and a fourth amount of the second component to a second mixing volume after a second delivery member is connected to the connector, and cause the fourth amount of the first component to crosslink with the fourth amount of the second component to form a second hydrogel in the second mixing volume.
4. The drive assembly includes:
3. The device of claim 1 or 2, configured to retain the second amount of the first component and the second amount of the second component within the delivery member for a residence time equal to or greater than a gelation time of the hydrogel.
5. The device of claim 1 or 2, wherein the delivered hydrogel is formulated to occlude at least a portion of a target area.
6. The device of claim 1 or 2, wherein the drive assembly is configured to transport the hydrogel from the delivery member in less than 30 seconds.
7. 3. The device of claim 1 or 2, wherein the drive assembly is configured to deliver about 50 microliters to about 200 microliters of the hydrogel from the delivery member in about 5 seconds to about 20 seconds.
8. the drive assembly further includes an electromechanical drive; 3. The device of claim 1 or 2, further comprising an electronic control system that generates a drive signal to control the electromechanical drive to maintain an outflow force of the hydrogel delivered from the delivery member below a flow force threshold.
9. the drive assembly further includes an electromechanical drive; 1. An electronic control system comprising:
3. The device of claim 1 or 2, further comprising an electronic control system that generates a drive signal to control the electromechanical drive to maintain a velocity of the hydrogel within the delivery member within a predetermined velocity range during the time that the hydrogel is transported to create a delivery volume.
10. coupling the delivery member to the connector such that a bolus of air is present within the mixing volume; 3. The device of claim 1 or 2, wherein delivering the second amount of the first component and the second amount of the second component into the mixing volume delivers the bolus of air into the target area before the hydrogel is delivered to the target area.
11. the first component is a first water-soluble polymer capable of biorthogonal linking chemistry; 3. The device of claim 1 or 2, wherein the second component is a second water-soluble polymer capable of biorthogonal linking chemistry such that the first component can be crosslinked with the second component to form the hydrogel.
12. The hydrogel is a higher-order structure in which a chemical reaction between the first component and the second component in the delivery member is completed; The device of claim 1 or 2, wherein the hydrogel is configured to be carried away as the conformation through an outflow opening of the delivery member.
Citation Information
Patent Citations
Medical devices with improved ultrasound visibility
JP2006520220A
Gel material and manufacturing method therefor
JP2016155994A
Devices, systems, and methods for medicament delivery
US20100318035A1
Adipose tissue combinations, devices, and uses thereof
US20140276384A1
Methods and apparatus for automated, microvolume delivery of biomaterials
US62760650P0
